Union Security Life Insurance Co Of New York S-1 16 Apr 24 IPO registration Financial data

Document and Entity Information

Document and Entity Information	12 Months Ended
	Dec. 31, 2023
Cover [Abstract]
Entity Registrant Name	UNION SECURITY LIFE INSURANCE CO OF NEW YORK
Entity Central Index Key	0000914804
Document Type	S-1
Amendment Flag	false
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false

Balance Sheets

Balance Sheets - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Investments:
Fixed maturity securities available for sale, at fair value (amortized cost — $10.0 in 2023 and $10.2 in 2022)	$ 9.3	$ 9.2
Short-term investments	1.6	1.6
Total investments	10.9	10.8
Cash and cash equivalents	0.7	0.4
Reinsurance recoverables (net of allowances for credit losses of $0.3 and $0.5 at December 31, 2023 and 2022, respectively)	437.3	452.7
Other assets	2.6	2.7
Assets held in separate accounts	10.2	10.1
Total assets	461.7	476.7
Liabilities
Future policy benefits and expenses	420.9	434.9
Unearned premiums	1.9	2
Claims and benefits payable	15.7	17.1
Deferred gain on disposal of businesses	0.4	0.6
Accounts payable and other liabilities	0.5	0.2
Liabilities related to separate accounts	10.2	10.1
Total liabilities	449.6	464.9
Commitments and contingencies (Note 13)
Stockholder's equity
Common stock, par value $20 per share, 100,000 shares authorized, issued, and outstanding	2	2
Additional paid-in capital	10.7	10.7
Retained earnings (deficit)	0	(0.2)
Accumulated other comprehensive income	(0.6)	(0.7)
Total stockholder's equity	12.1	11.8
Total liabilities and stockholder's equity	$ 461.7	$ 476.7

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Amortized cost	$ 10	$ 10.2
Reinsurance recoverable, allowance for credit loss	$ 0.3	$ 0.5
Common stock, par value (in dollars per share)	$ 20	$ 20
Common stock, shares authorized (in shares)	100,000	100,000
Common stock, shares issued (in shares)	100,000	100,000
Common stock, shares outstanding (in shares)	100,000	100,000

Statements of Operations

Statements of Operations - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenues
Net earned premiums	$ 0.2	$ 0.3	$ 0.5
Net investment income	0.4	1.3	1.3
Net realized (losses) gains on investments	0	(1.1)	0.2
Amortization of deferred gains on disposal of businesses	0.2	0.2	0.2
Total revenues	0.8	0.7	2.2
Benefits, losses and expenses
Policyholder benefits	0.1	0.5	0.2
Underwriting, general and administrative expenses	0.5	1	0.5
Total benefits, losses and expenses	0.6	1.5	0.7
Income (loss) before (benefit) provision for income taxes	0.2	(0.8)	1.5
(Benefit) provision for income taxes	0	(0.2)	0.3
Net income (loss)	$ 0.2	$ (0.6)	$ 1.2

Statements of Comprehensive Inc

Statements of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 0.2	$ (0.6)	$ 1.2
Other comprehensive income (loss):
Change in unrealized gains on securities, net of taxes of $— million, $0.8 million, and $0.3 million, respectively	0.1	(2.9)	(1.2)
Total other comprehensive income (loss)	0.1	(2.9)	(1.2)
Total comprehensive income (loss)	$ 0.3	$ (3.5)	$ 0

Statements of Comprehensive I_2

Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Statement of Comprehensive Income [Abstract]
Change in unrealized gains on securities, taxes	$ 0	$ 0.8	$ 0.3

Statements of Changes in Stockh

Statements of Changes in Stockholder's Equity - USD ($) $ in Millions		Total	Common Stock	Additional Paid-in Capital	Retained Earnings (Deficit)	Accumulated Other Comprehensive Income
Beginning Balance at Dec. 31, 2020		$ 46.5	$ 2	$ 39.6	$ 1.5	$ 3.4
Equity
Net income (loss)		1.2			1.2
Dividends to Parent		(1.2)			(1.2)
Other comprehensive loss		(1.2)				(1.2)
Ending Balance at Dec. 31, 2021		45.3	2	39.6	1.5	2.2
Equity
Net income (loss)		(0.6)			(0.6)
Dividends to Parent	[1]	(30)		(28.9)	(1.1)
Other comprehensive loss		(2.9)				(2.9)
Ending Balance at Dec. 31, 2022		11.8	2	10.7	(0.2)	(0.7)
Equity
Net income (loss)		0.2			$ 0.2
Other comprehensive loss		0.1				0.1
Ending Balance at Dec. 31, 2023		$ 12.1	$ 2	$ 10.7		$ (0.6)
[1]Dividends are required to be deducted from retained earnings available as of the dividend date and when depleted, deducted from additional paid-in capital and treated as a return of capital.

Statements of Cash Flows

Statements of Cash Flows - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Operating activities
Net income (loss)		$ 0.2	$ (0.6)	$ 1.2
Noncash revenues, expenses, gains and losses included in income:
Amortization of deferred gains on disposal of businesses		(0.2)	(0.2)	(0.2)
Depreciation and amortization		0	0.1	0.1
Deferred tax expense		0.2	(0.5)	0
Net realized losses (gains) on investments		0	1.1	(0.2)
Changes in operating assets and liabilities:
Reinsurance recoverable		0	0.1	0.5
Insurance policy reserves and expenses		(0.1)	0.4	(0.6)
Other assets and other liabilities		0.2	0.2	(0.2)
Taxes payable		(0.3)	0	0.1
Other		0.2	0.1	0.1
Net cash provided by operating activities		0.2	0.7	0.8
Sales of:
Fixed maturity securities available for sale		0	1	9.1
Maturities, prepayments, and scheduled redemption of:
Fixed maturity securities available for sale		0.6	5.6	12.7
Purchases of:
Fixed maturity securities available for sale		(0.5)	(16.2)	(13.4)
Change in short-term investments		0	10.4	(7.9)
Net cash provided by investing activities		0.1	0.8	0.5
Financing activities
Cash dividends paid	[1]	0	(1.7)	(1.2)
Net cash used in financing activities		0	(1.7)	(1.2)
Change in cash and cash equivalents		0.3	(0.2)	0.1
Cash and cash equivalents at beginning of period		0.4	0.6	0.5
Cash and cash equivalents at end of period		0.7	0.4	0.6
Supplemental information:
Income taxes paid		$ 0.1	$ 0.3	$ 0.2
[1]For the year ended 2022, the Company had a $28.3 million non-cash extraordinary dividend. See Note 7 for additional information.

Statements of Cash Flows (Paren

Statements of Cash Flows (Parenthetical) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($)
Statement of Cash Flows [Abstract]
Non-cash dividend	$ 28.3

Nature of Operations and Items

Nature of Operations and Items Impacting Basis of Presentation	12 Months Ended
	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NATURE OF OPERATIONS AND ITEMS IMPACTING BASIS OF PRESENTATION	NATURE OF OPERATIONS AND ITEMS IMPACTING BASIS OF PRESENTATION Overview: Union Security Life Insurance Company of New York (the "Company") is domiciled in New York and is a provider of life, health, annuity insurance, credit life and credit disability products. The Company's financial statements also reflect the assets, liabilities and activity associated with businesses that were sold through reinsurance and coinsurance arrangements. In 2016 Assurant entered into a reinsurance agreement with Sun Life and Health Insurance Company (U.S.) ("Sun Life") for the sale of its Assurant Employee Benefits ("AEB") segment. In 2001, Assurant entered into a reinsurance agreement with Talcott Resolution (formerly owned by The Hartford) for the sale of the Fortis Financial Group ("FFG") division. In 2000, the Company divested its Long-Term Care ("LTC") operations to John Hancock Life Insurance Company, a subsidiary of Manulife Financial Corporation ("John Hancock"). Assets supporting liabilities ceded relating to these businesses are mainly held in trusts and the separate accounts relating to FFG are still reflected in the Company's balance sheet. The Company is a wholly-owned subsidiary of the Parent. The Parent's common stock is traded on the New York Stock Exchange under the symbol "AIZ".

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). Amounts are presented in United States of America ("U.S.") dollars and all amounts are in millions, except for number of shares, per share amounts and number of loans. Use of Estimates The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts. The items affected by the use of estimates include but are not limited to, investments, reinsurance recoverables, other assets, future policy benefits and expenses, unearned premiums, claims and benefits payable, deferred gain on disposal of businesses, and commitments and contingencies. The estimates are sensitive to market conditions, investment yields, mortality, morbidity, commissions and other acquisition expenses, policyholder behavior and other factors. Actual results could differ from the estimates recorded. The Company believes all amounts reported are reasonable and adequate. Fair Value The Company uses an exit price for its fair value measurements. An exit price is defined as the amount received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In measuring fair value, the Company gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. See Note 5 for additional information. Investments Fixed maturity securities are classified as available-for-sale as defined in the investments guidance and are reported at fair value. If the fair value is higher than the amortized cost for fixed maturity securities, the excess is an unrealized gain; and, if lower than amortized cost, the difference is an unrealized loss. Net unrealized gains and losses on securities classified as available-for-sale, less deferred income taxes, are included in AOCI. Presentation of credit-related impairments is shown as an allowance, recognizing credit impairments upon purchase of securities as applicable, and requiring reversals of previously recognized credit-related impairments when applicable. For available for sale fixed maturity securities in an unrealized loss position for which the Company does not intend to sell or for which it is more likely than not that the Company would not be required to sell before an anticipated recovery in value, the Company evaluates whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost basis, changes to the credit rating of the security by a nationally recognized statistical ratings organization and any adverse conditions specifically related to the security, industry or geographic area, among other factors. If this assessment indicates a potential credit loss may exist, the present value of cash flows expected to be collected are compared to the security’s amortized cost basis. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit-related impairment exists, and a charge to income and an associated allowance for credit losses is recorded for the credit-related impairment. Any impairment not related to credit losses is recorded through other comprehensive income. The amount of the allowance for credit losses is limited to the amount by which fair value is less than the amortized cost basis. Upon recognizing a credit-related impairment, the cost basis of the security is not adjusted. Subsequent changes in the allowance for credit losses are recorded as provision for, or reversal of, credit loss expense. For fixed maturities where the Company records a credit loss, a determination is made as to the cause of the impairment and whether the Company expects a recovery in the value. Write-offs are charged against the allowance when management concludes the financial asset is uncollectible. For fixed maturities where the Company expects a recovery in value, the effective yield method is utilized, and the investment is amortized to par. For available for sale fixed maturity securities that the Company intends to sell, or for which it is more likely than not that the Company will be required to sell before recovery of its amortized cost basis, the entire impairment loss, or difference between the fair value and amortized cost basis of the security, is recognized in net realized gains (losses). The new cost basis of the security is the previous amortized cost basis less the impairment recognized and is not adjusted for any subsequent recoveries in fair value. The Company reports receivables for accrued investment income separately from fixed maturities available for sale and elected not to measure allowances for credit losses for accrued investment income as uncollectible balances are written off in a timely manner. Accrued investment income is included in other assets. Short-term investments include securities and other investments with durations of one year or less, but greater than three months, between the date of purchase and maturity. These amounts are reported at cost or amortized cost, which approximates fair value. Realized gains and losses on sales of investments are recognized on the specific identification basis. Investment income is recorded as earned and reported net of investment expenses. The Company anticipates prepayments of principal in the calculation of the effective yield for mortgage-backed securities and structured securities. The retrospective method is used to adjust the effective yield for the majority of the Company's mortgage-backed and structured securities. For credit-sensitive or credit impaired structured securities, the effective yield is recalculated on a prospective basis, primarily our commercial mortgaged-backed,residential mortgage-backed and asset backed securities. Cash and Cash Equivalents The Company considers all highly liquid securities and other investments with durations of three months or less between the date of purchase and maturity to be cash equivalents. These amounts are carried at cost, which approximates fair value. Cash balances are reviewed at the end of each reporting period to determine if negative cash balances exist. If negative cash balances exist, the cash accounts are netted with other positive cash accounts of the same bank provided the right of offset exists between the accounts. If the right of offset does not exist, the negative cash balances are reclassified to accounts payable and other liabilities. Reinsurance For ceded reinsurance, risk transfer requirements must be met for reinsurance accounting to apply. If risk transfer requirements are not met, the contract is accounted for as a deposit, resulting in the recognition of cash flows under the contract through a deposit asset or liability and not as revenue or expense. To meet risk transfer requirements, a reinsurance contract must include both insurance risk, consisting of both underwriting and timing risk, and a reasonable possibility of a significant loss for the assuming entity. Similar risk transfer criteria are used to determine whether directly written insurance contracts should be accounted for as insurance or as a deposit. Reinsurance recoverables include amounts related to paid benefits and estimated amounts related to unpaid policy and contract claims, future policyholder benefits and policyholder contract deposits. The cost of reinsurance is recognized as a reduction to premiums earned over the terms of the underlying reinsured policies. Amounts recoverable from reinsurers are estimated in a manner consistent with claim and claim adjustment expense reserves or future policy benefits reserves and are reported in the balance sheets. The cost of reinsurance related to long-duration contracts is recognized over the life of the underlying reinsured policies. The ceding of insurance does not discharge the Company’s primary liability to insureds, thus a credit exposure exists to the extent that any reinsurer is unable to meet the obligation assumed in the reinsurance agreements. To mitigate this exposure to reinsurer insolvencies, the Company evaluates the financial condition of its reinsurers and typically holds collateral (in the form of funds withheld, trusts and letters of credit) as security under the reinsurance agreements. The Company accounts for credit losses using the expected credit loss model for reinsurance recoverables. The Company uses a probability of default and loss given default methodology in estimating the allowance, whereby the credit ratings of reinsurers are used in determining the probability of default. The allowance is established for reinsurance recoverables on paid and unpaid future policy benefits and claims and benefits. Prior to applying default factors, the net exposure to credit risk is reduced for any collateral for which the right of offset exists, such as funds withheld, assets held in trust and letters of credit, which are part of the reinsurance arrangements, with adjustments to include consideration of credit exposure on the collateral. The methodology used by the Company incorporates historical default factors for each reinsurer based on their credit rating using comparably rated bonds as published by a major ratings service. The allowance is based upon the Company’s ongoing review of amounts outstanding, length of collection periods, changes in reinsurer credit standing and other relevant factors. Reinsurance premiums assumed are calculated based upon payments received from ceding companies together with accrual estimates, which are based on both payments received and in-force policy information received from ceding companies. Any subsequent differences arising on such estimates are recorded in the period in which they are determined. Other Assets Other assets include prepaid items, deferred income tax assets and accrued investment income. Separate Accounts Assets and liabilities associated with separate accounts relate to premium and annuity considerations for variable annuity products for which the contract-holder, rather than the Company, bears the investment risk. Separate account assets (with matching liabilities) are reported at fair value. Revenues and expenses related to the separate account assets and liabilities, to the extent of benefits paid or provided to the separate account policyholders, are excluded from the amounts reported in the accompanying statements of operations because the underlying accounts involve investment-type annuity contracts and/or are subject to reinsurance. Reserves Reserves are established using generally accepted actuarial methods and reflect judgments about expected future premium and claim payments. Factors used in their calculation include experience derived from historical claim payments, expected future premiums and actuarial assumptions. Calculations incorporate assumptions about the incidence of incurred claims, the extent to which all claims have been reported, reporting lags, expenses, inflation rates, future investment earnings, internal claims processing costs and other relevant factors. The estimation of reserves includes an element of uncertainty given that management is using historical information and methods to project future events and reserve outcomes. The recorded reserves represent the Company’s best estimate at a point in time of the ultimate costs of settlement and administration of a claim or group of claims based upon actuarial assumptions and projections using facts and circumstances known at the time of calculation. The adequacy of reserves may be impacted by future trends in claims severity, frequency, judicial theories of liability and other factors. These variables are affected by both external and internal events, including: changes in the economic cycle, inflation, judicial trends, legislative changes and claims handling procedures. Many of these items are not directly quantifiable and not all future events can be anticipated when reserves are established. Reserve estimates are refined as experience develops. Adjustments to reserves, both positive and negative, are reflected in the statement of operations in the period in which such estimates are updated. Because establishment of reserves is an inherently complex process involving significant judgment and estimates, there can be no certainty that future settlement amounts for claims incurred through the financial reporting date will not vary from reported claims reserves. Future loss development could require reserves to be increased or decreased, which could have a material effect on the Company’s earnings in the periods in which such increases or decreases are made. However, based on information currently available, the Company believes its reserve estimates are adequate. The following table provides reserve information for our major product lines for the years ended December 31, 2023 and 2022: December 31, 2023 December 31, 2022 Claims and Benefits Payable Claims and Benefits Payable Future Unearned Case Incurred Future Unearned Case Incurred Long Duration Contracts: Universal life and other products no longer offered $ — $ — $ 0.4 $ — $ — $ — $ 0.4 $ — Disposed and run-off businesses 420.9 1.9 — — 434.9 2.0 — — Short Duration Contracts: Disposed and run-off businesses — — 15.1 0.2 — — 16.5 0.2 Total $ 420.9 $ 1.9 $ 15.5 $ 0.2 $ 434.9 $ 2.0 $ 16.9 $ 0.2 For additional information regarding our reserves, see Note 10. Long Duration Contracts The Company adopted the targeted improvements accounting guidance for long-duration insurance contracts as of January 1, 2023, using a modified retrospective method on liabilities for future policy benefits and expenses to January 1, 2021 for long-term care insurance contracts that have been fully reinsured. Under the transition guidance, the long-term care insurance contracts are grouped into cohorts based on the contract’s issue year. Premiums are recognized when due as net earned premiums in the statement of operations. A future policy benefits and expenses reserve is recorded as the present value of estimated future policy benefits and expenses less the present value of estimated future net premiums. The net premium ratio (“NPR”) approach is used to recognize a liability when expected insurance benefits are accrued over the life of the contract in proportion to premium revenue. Policy expense assumptions are locked in as of December 31, 2020 as the long-term care insurance products are in run-off as of the transition date. Actual premiums and benefits are recognized on a quarterly basis in the statement of operations allocated in proportion to prior period cash flow projections at the cohort level. The updated cash flows used in the calculation are discounted using the discount rate used in the last premium deficiency test update prior to December 31, 2020 (the “original discount rate”) and presented as interest expense in the statement of operations. The revised NPR is used to measure benefit expense based on the recognized premium revenue in the period. The difference between the updated future policy benefits and expenses reserve opening period and previous ending period due to updating the NPR is presented as a remeasurement gain or loss (e.g., a cumulative catch-up adjustment) in policyholder benefits in the Company’s statements of operations. A remeasurement of the ending reporting period future policy benefits and expenses reserve is calculated using the current upper medium grade fixed-income corporate bond instrument yield as of the balance sheet ending period (the “current discount rate”). The current discount rate used is an externally published US corporate A index weighted average spot rate that is updated quarterly and effectively matches the duration of the expected cash flow streams of the long-term care reserves. The difference between the ending period future policy benefits and expenses reserve measured using the original discount rate and the future policy benefits and expenses reserve measured using the current discount rate is recorded in AOCI in the Company’s statements of comprehensive income. The long-term care insurance contracts are fully reinsured and there is no impact to stockholders’ equity or net income as the reserves are fully reinsured. See Note 10 for additional information. Short Duration Contracts The Company’s short duration contracts include group insurance contracts no longer offered, as well as credit life, disability and mortgage accidental death contracts. For short duration contracts, claims and benefits payable reserves are recorded when insured events occur. The liability is based on the expected ultimate cost of settling the claims. The claims and benefits payable reserves include: (1) case reserves for known but unpaid claims as of the balance sheet date; (2) incurred but not reported (“IBNR”) reserves for claims where the insured event has occurred but has not been reported to the Company as of the balance sheet date; and (3) loss adjustment expense reserves for the expected handling costs of settling the claims. Factors used in the calculation include experience derived from historical claim payments and actuarial assumptions including loss development factors and expected loss ratios. Changes in the estimated liabilities are recorded as a charge or credit to policyholder benefits as estimates are updated. Contingencies A loss contingency is recorded if reasonably estimable and probable. The Company establishes reserves for these contingencies at the best estimate, or if no one estimated amount within the range of possible losses is more probable than any other, the Company records an estimated reserve at the low end of the estimated range. Contingencies affecting the Company primarily relate to legal and regulatory matters, which are inherently difficult to evaluate and are subject to significant changes. Premiums Long Duration Contracts Premiums for long term care insurance and life insurance contracts no longer offered are recognized as revenue when due from the policyholder. For investment-type annuity contracts, revenues consist of charges assessed against policy balances. Short Duration Contracts The Company’s short duration contracts revenue is recognized over the contract term in proportion to the amount of insurance protection provided. Underwriting, General and Administrative Expenses Underwriting, general and administrative expenses consist primarily of commissions, premium taxes, licenses, fees, salaries and personnel benefits, and other general operating expenses and are expensed as incurred. Income Taxes The Company reports its taxable income in a consolidated federal income tax return along with other affiliated subsidiaries of the Parent. Income tax expense or benefit is allocated among the affiliated subsidiaries by applying income tax rates to taxable income or loss determined on a separate return basis according to a tax allocation agreement. Entities with losses record current tax benefits to the extent such losses are utilized in the consolidated federal tax return. Current federal income taxes are recognized based upon amounts estimated to be payable or recoverable as a result of taxable operations for the current year. Deferred income taxes are recorded for temporary differences between the financial reporting basis and income tax basis of assets and liabilities, based on enacted tax laws and statutory tax rates applicable to the periods in which the Company expects the temporary differences to reverse. A valuation allowance is established for deferred tax assets when it is more likely than not that an amount will not be realized. The impact of changes in tax rates on all deferred tax assets and liabilities are required to be reflected within income on the enactment date, regardless of the financial statement component where the deferred tax originated. The Company classifies net interest expense related to tax matters and any applicable penalties as a component of income tax expense. Comprehensive Income Comprehensive income is comprised of net income, and net unrealized gains and losses on securities classified as available for sale, less deferred income taxes. Recent Accounting Pronouncements — Adopted Changes to GAAP are established by the Financial Accounting Standards Board ("FASB") in the form of Accounting Standards Updates ("ASUs") to the FASB Accounting Standards Codification. The Company considers the applicability and impact of all ASUs. The following tables provide a description of ASUs recently issued by the FASB and the impact of their adoption on the Company's financial statements. Adopted Accounting Pronouncements The table below describes the impacts of the ASUs adopted by the Company, effective January 1, 2023: Standard Summary of the Standard Effective date Method of Adoption Impact of the Standard on the Company's Financial Statements ASU 2018-12, The guidance includes the following primary changes: assumptions supporting liabilities for future policy benefits and expenses will no longer be locked-in but must be updated at least annually with the impact of changes to the liability reflected in earnings (except for discount rates); the discount rate assumptions will be based on upper-medium grade (low credit risk) fixed-income instrument yield instead of the earnings rate of invested assets; the discount rate must be evaluated at each reporting date and the impact of changes to the liability estimate as a result of updating the discount rate assumption is required to be recognized in other comprehensive income; the provision for adverse deviation is eliminated; and premium deficiency testing is eliminated. Other noteworthy changes include the following: differing models for amortizing deferred acquisition costs will become uniform for all long-duration In December 2022, the FASB issued guidance to provide January 1, 2023, to be The Company adopted this standard The adoption of this standard along Future Adoption of Accounting Pronouncements ASUs not listed below were assessed and either determined to be not applicable or are not expected to have a material impact on the Company's financial statements or disclosures. ASUs issued but not yet adopted as of December 31, 2023, that are currently being assessed and may or may not have a material impact on the Company's financial statements or disclosures are included. Standard Summary of the Standard Effective date Method of Adoption Impact of the Standard on the Company's Financial Statements ASU 2023-09 Income The guidance improves the transparency of income tax January 1, 2025 (with early adoption permitted for annual financial statements that have not yet been issued or made available for issuance). The Company is assessing when the

Allowance for Credit Losses

Allowance for Credit Losses	12 Months Ended
	Dec. 31, 2023
Credit Loss [Abstract]
Allowance for Credit Losses	ALLOWANCE FOR CREDIT LOSSES The total allowance for credit losses is entirely related to reinsurance recoverables and was $0.3 million and $0.5 million as of December 31, 2023 and 2022, respectively. For the year ended December 31, 2023, the net decrease in the allowance for credit losses that increased pre-tax income was $0.2 million, which is included in underwriting, general and administrative expenses. Reinsurance Recoverables As part of the Company’s overall risk and capacity management strategy, reinsurance is used to mitigate all risks underwritten by the Company. The Company is exposed to the credit risk of reinsurers, as the Company remains liable to insureds regardless of whether related reinsurance recoverables are collected. As of December 31, 2023 and 2022, reinsurance recoverables totaled $437.3 million and $452.7 million, respectively, the majority of which are protected from credit risk by various types of collateral or other risk mitigation mechanisms, such as trusts and letters of credit or by withholding the assets in a modified coinsurance or funds withheld arrangement. The Company utilizes external credit ratings published by S&P Global Ratings, a division of S&P Global Inc., at the balance sheet date when determining the allowance. Where rates are not available, the Company assigns default credit ratings based on if the reinsurer is authorized or unauthorized. Of the total recoverables subject to the allowance, 100% were rated A- or better and 0% were rated BBB or BB for the year ended December 31, 2023; and 97% were rated A- or better and 3% were rated BBB or BB for the year ended December 31, 2022. The following table presents the changes in the allowance for credit losses for reinsurance recoverables for the periods indicated: Total Balance, December 31, 2021 $ 0.3 Current period change for credit losses 0.2 Balance, December 31, 2022 0.5 Current period change for credit losses $ (0.2) Balance, December 31, 2023 $ 0.3

Investments

Investments	12 Months Ended
	Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]
INVESTMENTS	INVESTMENTS The following tables show the cost or amortized cost, gross unrealized gains and losses, and fair value of the Company's fixed maturity securities as of the dates indicated: December 31, 2023 Cost or Gross Gross Fair Value Fixed maturity securities: U.S. government and government agencies and authorities $ 1.9 $ — $ (0.1) $ 1.8 States, municipalities and political subdivisions 0.5 — — 0.5 Foreign governments 0.2 — — 0.2 Asset backed securities 0.1 — — 0.1 Residential mortgage-backed 4.8 — (0.7) 4.1 U.S. corporate 2.1 0.1 — 2.2 Foreign corporate 0.4 — — 0.4 Total fixed maturity securities $ 10.0 $ 0.1 $ (0.8) $ 9.3 December 31, 2022 Cost or Gross Gross Fair Value Fixed maturity securities: U.S. government and government agencies and authorities $ 1.9 $ — $ (0.2) $ 1.7 States, municipalities and political subdivisions 0.5 — — 0.5 Foreign governments 0.3 — — 0.3 Residential mortgage-backed 5.3 — (0.8) 4.5 U.S. corporate 1.9 — — 1.9 Foreign corporate 0.3 — — 0.3 Total fixed maturity securities $ 10.2 $ — $ (1.0) $ 9.2 The cost or amortized cost and fair value of fixed maturity securities at December 31, 2023 by contractual maturity are shown below. Actual maturities may differ from contractual maturities because issuers of the securities may have the right to call or prepay obligations with or without call or prepayment penalties. December 31, 2023 Cost or Fair Due in one year or less $ 2.0 $ 2.0 Due after one year through five years 1.8 1.7 Due after five years through ten years 1.3 1.4 Due after ten years — — Total 5.1 5.1 Asset backed securities 0.1 0.1 Residential mortgage-backed 4.8 4.1 Total $ 10.0 $ 9.3 The following table shows the major categories of net investment income for the periods indicated: Years Ended December 31, 2023 2022 2021 Fixed maturity securities $ 0.3 $ 1.3 $ 1.4 Short term investments 0.1 — — Total investment income 0.4 1.3 1.4 Investment expenses — — (0.1) Net investment income $ 0.4 $ 1.3 $ 1.3 No material investments of the Company were non-income producing for the years ended December 31, 2023, 2022 and 2021. The following table summarizes the proceeds from sales of available-for-sale fixed maturities and the gross realized gains and gross realized losses that have been recognized in the statement of operations as a result of those sales for the periods indicated: Years Ended December 31, 2023 2022 2021 Proceeds from sales $ — $ 29.4 $ 9.1 Gross realized gains — 0.7 0.2 Gross realized losses — (1.8) — Net realized gains (losses) from sales of fixed maturity securities $ — $ (1.1) $ 0.2 The following table sets forth the net realized gains (losses) recognized in the statement of operations for the periods indicated: Years Ended December 31, 2023 2022 2021 Net realized gains (losses) related to sales: Net realized gains (losses) from sales of fixed maturity securities $ — $ (1.1) $ 0.2 The Company had fixed maturity securities of $0.8 million as of December 31, 2023 and 2022, on deposit with various governmental authorities as required by law.

Fair Value Disclosures

Fair Value Disclosures	12 Months Ended
	Dec. 31, 2023
Fair Value Disclosures [Abstract]
FAIR VALUE DISCLOSURES	FAIR VALUE DISCLOSURES Fair Values, Inputs and Valuation Techniques for Financial Assets and Liabilities Disclosures The fair value measurements and disclosure guidance defines fair value and establishes a framework for measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company has categorized its recurring fair value basis financial assets and liabilities into a three-level fair value hierarchy based on the priority of the inputs to the valuation technique. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety. The Company's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and takes into account factors specific to the asset or liability. The levels of the fair value hierarchy are described below: • Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company can access. • Level 2 inputs utilize other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. Level 2 inputs include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active and inputs other than quoted prices that are observable in the marketplace for the asset or liability. The observable inputs are used in valuation models to calculate the fair value for the asset or liability. • Level 3 inputs are unobservable but are significant to the fair value measurement for the asset or liability, and include situations where there is little, if any, market activity for the asset or liability. These inputs reflect management's own assumptions about the assumptions a market participant would use in pricing the asset or liability. The Company reviews fair value hierarchy classifications on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification of levels for certain securities within the fair value hierarchy. The following tables present the Company's fair value hierarchy for assets and liabilities measured at fair value on a recurring basis as of December 31, 2023 and 2022. The amounts presented below for cash equivalents and assets held in and liabilities related to separate accounts differ from the amounts presented in the balance sheet because only certain investments or certain assets and liabilities within these line items are measured at estimated fair value. The fair value amount and the majority of the associated levels presented for assets and liabilities held in separate accounts are received directly from third parties. December 31, 2023 Total Level 1 Level 2 Level 3 Financial Assets Fixed maturity securities: U.S. government and government agencies and authorities $ 1.8 $ — $ 1.8 $ — States, municipalities and political subdivisions 0.5 — 0.5 — Foreign governments 0.2 — 0.2 — Asset-backed 0.1 — 0.1 — Residential mortgage-backed 4.1 — 4.1 — U.S. corporate 2.2 — 2.2 — Foreign corporate 0.4 — 0.4 — Short-term investments 1.6 1.6 (1) — — Cash equivalents 0.7 0.7 (1) — — Assets held in separate accounts 10.2 6.0 (2) 4.2 (3) — Total financial assets $ 21.8 $ 8.3 $ 13.5 $ — Financial Liabilities Liabilities related to separate accounts $ 10.2 $ 6.0 (2) $ 4.2 (3) $ — December 31, 2022 Total Level 1 Level 2 Level 3 Financial Assets Fixed maturity securities: U.S. government and government $ 1.8 $ — $ 1.8 $ — States, municipalities and political subdivisions 0.5 — 0.5 — Foreign governments 0.2 — 0.2 — Residential mortgage-backed 4.5 — 4.5 — U.S. corporate 1.9 — 1.9 — Foreign corporate 0.3 — 0.3 — Short-term investments 1.6 1.6 (1) — — Cash equivalents 0.1 0.1 (1) — — Assets held in separate accounts 10.1 4.8 (2) 5.3 (3) — Total financial assets $ 21.0 $ 6.5 $ 14.5 $ — Financial Liabilities Liabilities related to separate accounts $ 10.1 $ 4.8 (2) $ 5.3 (3) $ — (1) Primarily includes money market funds. (2) Primarily includes mutual funds and related obligations. (3) Primarily includes fixed maturity securities and related obligations. Three different valuation techniques can be used in determining fair value for financial assets and liabilities: the market, income or cost approaches. The three valuation techniques described in the fair value measurements and disclosures guidance are consistent with generally accepted valuation methodologies. The market approach valuation techniques use prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. When possible, quoted prices (unadjusted) in active markets are used as of the period-end date (such as for mutual funds and money market funds). Otherwise, the Company uses valuation techniques consistent with the market approach including matrix pricing and comparables. Matrix pricing is a mathematical technique employed principally to value debt securities without relying exclusively on quoted prices for those securities but, rather, relying on the securities' relationship to other benchmark quoted securities. Market approach valuation techniques often use market multiples derived from a set of comparables. Multiples might lie in ranges with a different multiple for each comparable. The selection of where within the range the appropriate multiple falls requires judgment, considering both qualitative and quantitative factors specific to the measurement. Income approach valuation techniques convert future amounts, such as cash flows or earnings, to a single present amount, or a discounted amount. These techniques rely on current market expectations of future amounts as of the period-end date. Cost approach valuation techniques are based upon the amount that would be required to replace the service capacity of an asset at the period-end date, or the current replacement cost. That is, from the perspective of a market participant (seller), the price that would be received for the asset is determined based on the cost to a market participant (buyer) to acquire or construct a substitute asset of comparable utility, adjusted for obsolescence. While not all three approaches are applicable to all financial assets or liabilities, where appropriate, the Company may use one or more valuation techniques. For all the classes of financial assets and liabilities included in the above hierarchy, the Company generally uses the market valuation technique. Level 1 Securities The Company's investments and liabilities classified as Level 1 as of December 31, 2023 and 2022, consisted of mutual funds and related obligations and money market funds that are publicly listed and/or actively traded in an established market. Level 2 Securities The Company values Level 2 securities using various observable market inputs obtained from a pricing service or asset manager. They prepare estimates of fair value measurements for the Company’s Level 2 securities using proprietary valuation models based on techniques such as matrix pricing which include observable market inputs. The fair value measurements and disclosures guidance defines observable market inputs as the assumptions market participants would use in pricing the asset or liability developed on market data obtained from sources independent of the Company. The extent of the use of each observable market input for a security depends on the type of security and the market conditions at the balance sheet date. Depending on the security, the priority of the use of observable market inputs may change as some observable market inputs may not be relevant or additional inputs may be necessary. The Company uses the following observable market inputs (“standard inputs”), listed in the approximate order of priority, in the pricing evaluation of Level 2 securities: benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data including market research data. Further details for level 2 investment types follow: U.S. government and government agencies and authorities: U.S. government and government agencies and authorities securities are priced by the Company's pricing service utilizing standard inputs. Included in this category are U.S. Treasury securities which are priced using vendor trading platform data in addition to the standard inputs. States, municipalities and political subdivisions: States, municipalities and political subdivisions securities are priced by the Company's pricing service using material event notices and new issue data inputs in addition to the standard inputs. Foreign governments: Foreign government securities are priced by the Company's pricing service using standard inputs. The pricing service also evaluates each security based on relevant market information including relevant credit information, perceived market movements and sector news. Residential mortgage-backed and asset-backed: Residential mortgage-backed and asset-backed securities are priced by the Company's pricing service and asset managers using monthly payment information and collateral performance information in addition to the standard inputs. Additionally, asset-backed securities utilize new issue data while residential mortgage-backed securities utilize vendor trading platform data. U.S. and foreign corporate: Corporate securities are priced by the Company's pricing service using standard inputs. Non-investment grade securities within this category are priced by the Company's pricing service and asset managers using observations of equity and credit default swap curves related to the issuer in addition to the standard inputs. Short-term investments, cash equivalents, and assets held in separate accounts and liabilities related to separate accounts: To price the fixed maturity securities and related obligations in these categories, the pricing service utilizes the standard inputs. Valuation models used by the pricing service can change from period to period, depending on the appropriate observable inputs that are available at the balance sheet date to price a security. Management evaluates the following factors in order to determine whether the market for a financial asset is inactive. The factors include: • whether there are few recent transactions, • whether little information is released publicly, • whether the available prices vary significantly over time or among market participants, • whether the prices are stale (i.e., not current), and • the magnitude of the bid-ask spread. Illiquidity did not have a material impact in the fair value determination of the Company's financial assets as of December 31, 2023 or 2022. The Company generally obtains one price for each financial asset. The Company performs a periodic analysis to assess if the evaluated prices represent a reasonable estimate of the financial assets' fair values. This process involves quantitative and qualitative analysis and is overseen by investment and accounting professionals. Examples of procedures performed include initial and on-going review of pricing service methodologies, review of the prices received from the pricing service, review of pricing statistics and trends, and comparison of prices for certain securities with two different appropriate price sources for reasonableness. Following this analysis, the Company generally uses the best estimate of fair value based upon all available inputs. On infrequent occasions, a non-pricing service source may be more familiar with the market activity for a particular security than the pricing service. In these cases, the price used is taken from the non-pricing service source. The pricing service provides information to indicate which securities were priced using market observable inputs so that the Company can properly categorize the Company's assets in the fair value hierarchy. Fair Value of Financial Instruments Disclosures The financial instruments guidance requires disclosure of fair value information about financial instruments, for which it is practicable to estimate such fair value. Therefore, it requires fair value disclosure for financial instruments that are not recognized or are not carried at fair value in the balance sheet. However, this guidance excludes certain financial instruments, including those related to insurance contracts. For the financial instruments included within the following financial assets and financial liabilities, the carrying value in the balance sheet equals or approximates fair value. Please refer to the Fair Value Inputs and Valuation Techniques for Financial Assets and Liabilities Disclosures section above for additional information on the financial instruments included within the following financial assets and financial liabilities and the methods and assumptions used to estimate fair value: • Cash and cash equivalents; • Fixed maturity securities; • Short-term investments; • Assets held in separate accounts; and • Liabilities related to separate accounts. In estimating the fair value of the financial instruments that are not recognized or are not carried at fair value in the balance sheet, the Company used the following methods and assumptions: Policy reserves under investment products: the fair values for the Company's policy reserves under investment products are determined using discounted cash flow analysis. Key inputs to the valuation include projections of policy cash flows, reserve run-off, market yields and risk margins. The following tables disclose the carrying value, fair value and hierarchy level of the financial instruments that are not recognized or are not carried at fair value in the balance sheet as of the dates indicated: December 31, 2023 Fair Value Carrying Total Level 1 Level 2 Level 3 Financial Liabilities Policy reserves under investment products $ 4.8 $ 5.3 $ — $ — $ 5.3 December 31, 2022 Fair Value Carrying Total Level 1 Level 2 Level 3 Financial Liabilities Policy reserves under investment products (Individual and group annuities, subject to discretionary withdrawal) (1) $ 4.9 $ 5.1 $ — $ — $ 5.1 (1) Only the fair value of the Company's policy reserves for investment-type contracts (those without significant mortality or morbidity risk) are reflected in the table above.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2023
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The Company is subject to U.S. tax and files a U.S. consolidated federal income tax return with its Parent. All of the Company’s income comes from domestic sources. The components of income tax expense (benefit) were as follows for the periods indicated: Years Ended December 31, 2023 2022 2021 Current expense $ (0.2) $ 0.3 $ 0.3 Deferred expense (benefit) 0.2 (0.5) — Total income tax expense $ — $ (0.2) $ 0.3 A reconciliation of the federal income tax rate to the Company's effective income tax rate follows: December 31, 2023 2022 2021 Federal income tax rate: 21.0 % 21.0 % 21.0 % Reconciling items: Tax exempt interest (2.5) 0.6 (1.3) Dividend received deduction (2.1) 0.5 (0.3) Other (0.8) (0.3) — Effective income tax rate: 15.6 % 21.8 % 19.4 % The Company had no liability for unrecognized tax benefits as of and for each of the years ended December 31, 2023, 2022, and 2021.The Company does not anticipate any significant increase in the unrecognized tax benefit within the next 12 months. The Parent files its consolidated income tax returns in the U.S. and various state jurisdictions. The Parent has substantially concluded all U.S. federal income tax matters for years through 2015. The tax effects of temporary differences that result in deferred tax assets and deferred tax liabilities are as follows: December 31, 2023 2022 Deferred tax assets Deferred acquisition costs $ 1.6 $ 1.6 Deferred gain on disposal of business 0.1 0.1 Investments, net 0.2 0.3 Net unrealized appreciation on securities 0.2 0.2 Other 0.2 0.3 Total deferred tax assets 2.3 2.5 Deferred tax liabilities Net unrealized appreciation on securities — — Total deferred tax liabilities — — Net deferred income tax assets $ 2.3 $ 2.5 The calculation of the valuation allowance is made at the consolidated return group level. No cumulative valuation allowance has been recorded because it is management’s assessment that it is more likely than not that the gross deferred tax assets in the table above will be realized. The Company’s ability to realize deferred tax assets depends on its ability to generate sufficient taxable income of the same character within the carryback or carryforward periods. In assessing future taxable income, the Company considered all sources of taxable income available to realize its deferred tax asset, including the future reversal of existing temporary differences, future taxable income exclusive of reversing temporary differences and carryforwards, taxable income in carryback years and tax-planning strategies. If changes occur in the assumptions underlying the Company’s tax-planning strategies or in the scheduling of the reversal of the Company’s deferred tax liabilities, a valuation allowance may need to be recorded in the future. At December 31, 2023, the Company had no net operating loss, capital loss or tax credit carryforwards for U.S. federal income tax purposes.

Stockholder's Equity

Stockholder's Equity	12 Months Ended
	Dec. 31, 2023
Stockholders' Equity Note [Abstract]
STOCKHOLDER'S EQUITY	STOCKHOLDER'S EQUITY The Board of Directors of the Company has authorized 100,000 shares of common stock with a par value of $20 per share. All shares are issued and outstanding as of December 31, 2023 and 2022 and are owned by the Parent (see Note 1 to the Financial Statements). The Company paid cash dividends to its Parent of $0.0 million, $1.7 million, and $1.2 million during the years ended December 31, 2023, 2022 and 2021, respectively. The Company paid an extraordinary dividend, which was treated as a return of capital of $28.9 million, of which $28.3 million was non-cash during the year ended December 31, 2022. The maximum amount of dividends which can be paid by State of New York insurance companies to shareholders without prior approval of the New York Department of Financial Services is subject to restrictions relating to statutory surplus (see as described in Note 8 to the Financial Statements).

Statutory Information

Statutory Information	12 Months Ended
	Dec. 31, 2023
Insurance [Abstract]
STATUTORY INFORMATION	STATUTORY INFORMATION The Company prepares an Annual Statement on the basis of statutory accounting principles (“SAP”) prescribed or permitted by the New York State Department of Commerce. Prescribed SAP includes the Accounting Practices and Procedures Manual of the National Association of Insurance Commissioners (“NAIC”) as well as state laws, regulations and administrative rules. The principal differences between SAP and GAAP are: 1) policy acquisition costs are expensed as incurred under SAP, but are deferred and amortized under GAAP; 2) amounts collected from holders of universal life-type and annuity products are recognized as premiums when collected under SAP, but are initially recorded as contract deposits under GAAP, with cost of insurance recognized as revenue when assessed and other contract charges recognized over the periods for which services are provided; 3) the classification and carrying amounts of investments in certain securities are different under SAP than under GAAP; 4) the criteria for providing asset valuation allowances, and the methodologies used to determine the amounts thereof, are different under SAP than under GAAP; 5) the timing of establishing certain reserves, and the methodologies used to determine the amounts thereof, are different under SAP than under GAAP; 6) certain assets are not admitted for purposes of determining surplus under SAP; 7) methodologies used to determine the amounts of deferred taxes are different under SAP than under GAAP; 8) the criteria for obtaining reinsurance accounting treatment is different under SAP than under GAAP, and SAP allows net presentation of insurance reserves and reinsurance recoverables; and 9) deferred gains on the sale through reinsurance are recognized as a surplus under SAP and as a liability under GAAP. Reconciliations of net income and stockholder’s equity on the basis of statutory accounting to the related amounts presented in the accompanying statements were as follows: Net Income Stockholder's Equity 2023 2022 2021 2023 2022 Based on SAP $ (1.0) $ (0.1) $ 1.1 $ 10.8 $ 11.8 Policy and claim reserves 1.1 — — 1.1 — Investment valuation difference — — (0.1) (0.7) (1.0) Current income taxes (0.2) — — (0.2) — Deferred taxes (0.2) 0.5 — 0.3 0.4 Deferred gain on disposal of businesses and gains on disposal of businesses — — 0.1 (0.4) (0.6) Other differences 0.5 (1.0) 0.1 1.2 1.2 Based on GAAP $ 0.2 $ (0.6) $ 1.2 $ 12.1 $ 11.8 Insurance enterprises are required by state insurance departments to adhere to minimum risk based capital ("RBC") requirements developed by the NAIC. As of December 31, 2023, the Company exceeded minimum RBC requirements.

Reinsurance

Reinsurance	12 Months Ended
	Dec. 31, 2023
Reinsurance Disclosures [Abstract]
REINSURANCE	REINSURANCE The Company has predominantly sold all of its business through reinsurance with non-affiliated companies. The following table provides details of the reinsurance recoverables balance as of the dates indicated: 2023 2022 Ceded future policyholder benefits and expense $ 335.0 $ 348.6 Ceded unearned premium 1.9 2.0 Ceded claims and benefits payable 100.6 101.8 Ceded paid losses (0.2) 0.3 Total $ 437.3 $ 452.7 A key credit quality indicator for reinsurance is the A.M. Best Company ("A.M. Best") financial strength ratings of the reinsurer. A.M. Best financial strength ratings are an independent opinion of a reinsurer’s ability to meet ongoing obligations to policyholders. The A.M. Best ratings for the reinsurers in new reinsurance agreements where there is material credit exposure are reviewed at the time of execution. The A.M. Best ratings for existing reinsurance agreements are reviewed on a quarterly basis, or sooner based on developments. The following table provides the reinsurance recoverable as of December 31, 2023 grouped by A.M. Best financial strength ratings: A.M. Best ratings of Ceded future Ceded unearned Ceded claims Ceded paid Total A++ or A+ $ 330.1 $ 1.9 $ 100.6 $ 0.1 $ 432.7 B++ or B+ 4.9 — — — 4.9 Total 335.0 1.9 100.6 0.1 437.6 Less: Allowance — — — (0.3) (0.3) Total Reinsurance recoverable $ 335.0 $ 1.9 $ 100.6 $ (0.2) $ 437.3 The Company has used reinsurance to exit certain businesses, including the disposals of AEB, FFG and LTC. The reinsurance recoverables relating to these dispositions amounted to $436.9 million as of December 31, 2023. The three reinsurers with the largest reinsurance recoverable balances relating to these dispositions were Sun Life, John Hancock, and Talcott Resolution (formerly owned by The Hartford). The A.M. Best financial strength ratings of these three insurers were A+, A+ and B++, respectively. A.M. Best currently maintains a stable outlook on the financial strength ratings of Sun Life, John Hancock and Talcott Resolution. Most of the assets backing reserves relating to reinsurance recoverables from Sun Life, John Hancock and Talcott Resolution are held in trust. If these reinsurers become insolvent, the Company would be exposed to the risk that assets in the trusts and/or the separate accounts would be insufficient to support the liabilities that would revert back to the company. The following table presents the reinsurance recoverable from John Hancock, Sun Life, Talcott Resolution, and other reinsurers as of December 31, 2023 and 2022. Years Ended December 31, Reinsurer 2023 2022 John Hancock $ 416.1 $ 430.0 Sun Life 16.1 17.4 Talcott Resolution 4.7 4.9 Other reinsurers 0.4 0.4 Total $ 437.3 $ 452.7 The largest risk is with John Hancock. As of December 31, 2023 there is $879.4 million held in trust to support the coinsurance arrangement. If the value of the assets in this trust falls below the value of the associated statutory liabilities, John Hancock will be required to put more assets in the trust. Refer to Note 2 for additional information on the methodology. The effect of reinsurance on premiums earned and benefits incurred was as follows for the period indicated: Years Ended December 31, 2023 2022 2021 Long Short Total Long Short Total Long Short Total Direct earned premiums $ 6.5 $ 0.3 $ 6.8 $ 7.0 $ 0.4 $ 7.4 $ 8.1 $ 0.6 $ 8.7 Premiums ceded (6.5) (0.1) (6.6) (7.0) (0.1) (7.1) (8.1) (0.1) (8.2) Net earned premiums $ — $ 0.2 $ 0.2 $ — $ 0.3 $ 0.3 $ — $ 0.5 $ 0.5 Direct policyholder benefits $ 31.4 $ 1.3 $ 32.7 $ 30.3 $ 1.4 $ 31.7 $ 31.9 $ 0.5 $ 32.4 Policyholder benefits ceded (31.4) (1.2) (32.6) (30.3) (0.9) (31.2) (31.9) (0.3) (32.2) Net policyholder benefits $ — $ 0.1 $ 0.1 $ — $ 0.5 $ 0.5 $ — $ 0.2 $ 0.2 The Company utilizes ceded reinsurance for loss protection and capital management, client risk and profit sharing and business divestitures. Business Divestitures As referenced in Note 1, the Company has used reinsurance or coinsurance to sell certain businesses, such as for the disposals of AEB, FFG and LTC. The reinsurance agreement associated with the FFG sale also stipulates that Talcott Resolution contributes funds to increase the value of the separate account assets relating to annuity business sold if such value declines below the value of the associated liabilities. If Talcott Resolution fails to fulfill these obligations, the Company will be obligated to make these payments. In addition, the Company would be responsible for administering all of the reinsured or coinsured businesses in the event of reinsurer or coinsurer insolvency. The Company does not currently have the administrative systems and capabilities to process these businesses. Accordingly, the Company would need to obtain those capabilities in the event of an insolvency of one or more of the reinsurers or coinsurers of these businesses. The Company might be forced to obtain such capabilities on unfavorable terms with a resulting material adverse effect on our results of operations and financial condition. As of December 31, 2023, the Company was not aware of any regulatory actions taken with respect to the solvency of the insurance subsidiaries of Sun Life, John Hancock, or Talcott Resolution that reinsure the AEB, FFG and LTC businesses, and the Company has not been obligated to fulfill any of such reinsurers’ obligations. Sun Life, John Hancock, and Talcott Resolution have paid their obligations when due and there have been no disputes.

Reserves

Reserves	12 Months Ended
	Dec. 31, 2023
Insurance [Abstract]
RESERVES	RESERVES Short Duration Contracts The Company’s short duration contracts are mainly comprised of disposed and run-off business. The principal products and services included in these categories are described in the summary of significant accounting policies. See Note 2 to the Financial Statements for further information. Disposed and Run-off Short Duration Insurance Lines Run-off business includes certain medical policies no longer offered and AEB policies disposed of via reinsurance. Reserves for previously disposed business are included in the Company’s reserves in accordance with the insurance guidelines. The Company maintains an offsetting reinsurance recoverable related to the AEB reserves. See Note 9 to the Financial Statements for further information. Long Duration Contracts The Company’s long duration contracts are primarily comprised of life insurance policies (no longer offered), FFG and LTC disposed businesses. The principal products and services included in these categories are described in the summary of significant accounting policies. See Note 2 to the Financial Statements for further information. Disposed and Run-off Long Duration Insurance Lines Reserves for previously disposed FFG and LTC businesses are included in the Company’s reserves in accordance with the insurance guidance. The Company maintains an offsetting reinsurance recoverable related to these reserves. See Note 9 to the Financial Statements for additional information on previously disposed business. The following table presents the balances and changes in the long-term care future policy benefits and expense reserve: Years Ended December 31, 2023 2022 2021 Present value of expected net premiums Balance, beginning of period $ 34.2 $ 37.1 $ 44.4 Beginning balance at original discount rate 33.4 29.2 33.7 Effect of changes in cash flow assumptions (1) 1.5 9.4 (3.2) Effect of actual variances from expected experience 3.5 (2.7) (2.4) Adjusted beginning of period balance 38.4 35.9 28.1 Experience variance (2) — (0.3) 2.4 Interest accrual 2.8 4.6 6.0 Net premiums collected (4.7) (6.8) (7.3) Ending balance at original discount rate 36.5 33.4 29.2 Effect of changes in discount rate assumptions (0.1) 0.8 7.9 Balance, end of period $ 36.4 $ 34.2 $ 37.1 Present value of expected future policy benefits Balance, beginning of period $ 462.4 $ 658.5 $ 683.2 Beginning balance at original discount rate 444.4 430.0 421.7 Effect of changes in cash flow assumptions (1) — 12.3 (1.2) Effect of actual variances from expected experience 4.4 (3.3) (2.7) Adjusted beginning of period balance 448.8 439.0 417.8 Experience variance (2) 1.0 (1.2) (0.4) Interest accrual 19.5 24.7 29.3 Benefit payments (16.3) (18.1) (16.7) Ending balance at original discount rate 453.0 444.4 430.0 Effect of changes in discount rate assumptions (2.4) 18.0 228.5 Balance, end of period $ 450.6 $ 462.4 $ 658.5 Net future policy benefits and expenses $ 414.2 $ 428.2 $ 621.4 Related reinsurance recoverable 414.2 428.2 621.4 Net future policy benefits and expenses, after reinsurance recoverable $ — $ — $ — Weighted-average liability duration of the future policy benefits and expenses (in years) 12.0 12.7 13.0 (1) The increase for the years ending December 31, 2023 and 2022 was primarily due to historical experience reflecting a decreasing trend in lapse and mortality rates on the long-term care insurance products. The decrease for the years ending December 31, 2021 was primarily due to reduced expense assumptions. (2) Experience variance includes adverse development resulting from the allocation of the premium deficiency reserve to the cohort level for the issue years where net premiums exceed gross premiums. The following table presents a reconciliation of the long-term care net future policy benefits and expenses to the future policy benefits and expenses reserve in the balance sheet: December 31, 2023 December 31, 2022 Long-term care $ 414.2 $ 428.2 Other 6.7 6.7 Total $ 420.9 $ 434.9 The following table presents the amount of undiscounted expected future benefit payments and expected gross premiums for the long-term care insurance contracts: December 31, 2023 December 31, 2022 Expected future benefits payments $ 829.3 $ 850.0 Expected future gross premiums $ 69.4 $ 76.2 The following table presents the amount of long-term care revenue and interest recognized in the statements of operations: Years Ended December 31, 2023 2022 2021 Gross premiums $ 1.5 $ 1.7 $ 1.9 Interest expense (original discount rate) $ 5.6 $ 4.7 $ 5.1 The following table presents the weighted-average interest rate for long-term care insurance contracts: December 31, 2023 December 31, 2022 Interest expense (original discount rate) 5.95 % 5.95 % Current discount rate 6.01 % 5.52 % Concurrent with the transition period beginning January 1, 2021 for the adoption of ASU 2018-12, the Company elected to account for the long-term care insurance contracts using reserve updates on a quarter lag whereby the September 30, 2020 cash flow and other assumptions are used for the pre-adoption December 31, 2020 future policy benefits and expenses reserve. Under the modified retrospective method, the long-term care insurance contracts are grouped into cohorts based on the contract’s issue year. Premium deficiency reserves are allocated proportional to the cohort’s reserve balance as of the transition date of December 31, 2020. At the cohort level, the NPR calculation is performed, and the unlocking of the NPR for cohorts in excess of 100% is recognized through opening retained earnings. A balance sheet remeasurement of the revised future policy benefits and expenses reserve is recorded using the current discount rate as of December 31, 2020 with the remeasurement amount recorded through AOCI. Discount rate changes between the original and current discount rate as of December 31, 2020 were significant. The original discount rate at transition is a spot rate of 5.95% which is based on the most recent premium deficiency unlocking discount rate prior to transition using asset yields from investments allocated to the product at the time of the unlocking of the assumption. The current discount rate at transition was 1.69% reflecting prevailing interest rates as of December 31, 2020. The amended guidance has no impact to the statement stockholders’ equity or net income on the long-term care insurance contracts as the reserves are fully reinsured. The following table illustrates the impact of adoption on the long-term care insurance contracts: Future Policy Benefits and Expenses, pre-adoption December 31, 2020 $ 386.4 Effect of the remeasurement of the liability at current discount rate 250.8 Adjustment for loss contracts with NPR in excess of 100% under the modified retrospective approach 1.6 Adjusted balance, beginning of January 1, 2021 638.8 Less: reinsurance recoverable (638.8) Future Policy Benefits and Expenses, beginning of year January 1, 2021, net of reinsurance $ — The following table presents the effect of transition adjustments on stockholders' equity: January 1, 2021 Retained Earnings Accumulated Other Comprehensive Loss $ (1.6) $ (250.8) Reserve Roll Forward The following table provides a roll forward of the Company’s beginning and ending claims and benefits payable balances. Claims and benefits payable is the liability for unpaid loss and loss adjustment expenses and are comprised of case and IBNR reserves. Since unpaid loss and loss adjustment expenses are estimates, the Company’s actual losses incurred may be more or less than the Company’s previously developed estimates, which is referred to as either unfavorable or favorable development, respectively. The best estimate of ultimate loss and loss adjustment expenses is generally selected from a blend of methods that are applied consistently each period. There have been no significant changes in the methodologies and assumptions utilized in estimating the liability for unpaid loss and loss adjustment expenses for any of the periods presented. Years Ended December 31, 2023 2022 2021 Claims and benefits payable, at beginning of year $ 17.1 $ 19.1 $ 22.5 Less: Reinsurance ceded and other (17.0) (19.0) (22.4) Net claims and benefits payable, at beginning of year 0.1 0.1 0.1 Incurred losses and loss adjustment expenses related to: Current Year 0.9 0.1 0.3 Prior years (0.8) — — Total incurred losses and loss adjustment expenses 0.1 0.1 0.3 Paid losses and loss adjustment expenses related to: Current year 0.1 0.1 0.2 Prior years — — 0.1 Total paid losses and loss adjustment expenses 0.1 0.1 0.3 Net claims and benefits payable, at end of year 0.1 0.1 0.1 Plus: Reinsurance ceded and other 15.6 17.0 19.0 Claims and benefits payable, at end of year $ 15.7 $ 17.1 $ 19.1

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income	12 Months Ended
	Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
ACCUMULATED OTHER COMPREHENSIVE INCOME	ACCUMULATED OTHER COMPREHENSIVE INCOME Certain amounts included in the statement of comprehensive income are net of reclassification adjustments. The following tables summarize those reclassification adjustments (net of taxes) for the periods indicated: Year Ended December 31, 2023 Accumulated Balance at December 31, 2022 $ (0.7) Change in accumulated other comprehensive income (loss) before reclassifications 0.1 Amounts reclassified from accumulated other comprehensive income (loss) — Net current-period other comprehensive income (loss) 0.1 Balance at December 31, 2023 $ (0.6) Year Ended December 31, 2022 Accumulated Balance at December 31, 2021 $ 2.2 Change in accumulated other comprehensive income (loss) before reclassifications (3.8) Amounts reclassified from accumulated other comprehensive income (loss) 0.9 Net current-period other comprehensive income (loss) (2.9) Balance at December 31, 2022 $ (0.7) Year Ended December 31, 2021 Accumulated Balance at December 31, 2020 $ 3.4 Change in accumulated other comprehensive income (loss) before reclassifications $ (1.1) Amounts reclassified from accumulated other comprehensive income (loss) $ (0.1) Net current-period other comprehensive income (loss) $ (1.2) Balance at December 31, 2021 $ 2.2 (1) Accumulated other comprehensive income consists of net unrealized gains on securities. The following tables summarize the reclassifications out of AOCI for the periods indicated: Details about AOCI components Amount reclassified from AOCI Affected line item in the statement Years Ended December 31, 2023 2022 2021 Net unrealized gains (losses) on securities $ — $ 1.1 $ (0.1) Net realized gains (losses) on investments Tax effect — (0.2) — Provision for income taxes Total reclassifications for the period $ — $ 0.9 $ (0.1) Net of tax

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2023
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONS The Company receives various services from the Parent and its affiliates. These services include assistance in corporate insurance, accounting, tax, auditing, investment, information technology, actuarial, property management and other administrative functions. The net amounts paid for services and obligations to the Parent and its affiliates for the years ended December 31, 2023, 2022 and 2021 were $0.4 million, $0.5 million, $0.3 million, respectively. The Parent also pays all income tax payments on behalf of the Company. The income tax payments made by the Parent were $0.1 million, $0.3 million and $0.2 million for the years ended December 31, 2023, 2022 and 2021, respectively. Administrative expenses allocated to the Company may be greater or less than the expenses that would be incurred if the Company were operating as a separate company.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Legal and Regulatory Matters The Company is involved in a variety of litigation and legal and regulatory proceedings relating to its current and past business operations and, from time to time, it may become involved in other such actions. The Company continues to defend itself vigorously in these proceedings. The Company has participated and may participate in settlements on terms that the Company considers reasonable. The Company has established an accrued liability for certain legal and regulatory proceedings. The possible loss or range of loss resulting from such litigation and regulatory proceedings, if any, in excess of the amounts accrued is inherently unpredictable and uncertain. Consequently, no reasonable estimate can be made of any possible loss or range of loss in excess of the accrual. Although the Company cannot predict the outcome of any pending legal or regulatory proceeding, or the potential losses, fines, penalties or equitable relief, if any, that may result, it is possible that such outcome could have a material adverse effect on the Company's results of operations or cash flows for an individual reporting period. However, on the basis of currently available information, management does not believe that the pending matters are likely to have a material adverse effect, individually or in the aggregate, on the Company's financial condition.

Schedule I-Summary of Investmen

Schedule I-Summary of Investments Other-Than-Investments in Related Parties	12 Months Ended
	Dec. 31, 2023
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract]
Schedule I-Summary of Investments Other-Than-Investments in Related Parties	Schedule I — Summary of Investments Other-Than-Investments in Related Parties Cost or Fair Amount at (in millions) Fixed maturity securities: U.S. government and government agencies and authorities $ 1.9 $ 1.8 $ 1.8 States, municipalities and political subdivisions 0.5 0.5 0.5 Foreign governments 0.2 0.2 0.2 Asset backed securities 0.1 0.1 0.1 Residential mortgage-backed 4.8 4.1 4.1 U.S. corporate 2.1 2.2 2.2 Foreign corporate 0.4 0.4 0.4 Total fixed maturity securities 10.0 9.3 9.3 Short-term investments 1.6 1.6 1.6 Total investments $ 11.6 $ 10.9 $ 10.9

Schedule III-Supplementary Insu

Schedule III-Supplementary Insurance Information	12 Months Ended
	Dec. 31, 2023
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract]
Schedule III-Supplementary Insurance Information	Schedule III — Supplementary Insurance Information Future Unearned Claims and Premium Net Benefits Other (in millions) 2023 $ 420.9 $ 1.9 $ 15.7 $ 0.2 $ 0.4 $ 0.1 $ 0.5 2022 $ 434.9 $ 2.0 $ 17.1 $ 0.3 $ 1.3 $ 0.5 $ 1.0 2021 $ 628.3 $ 2.2 $ 19.2 $ 0.5 $ 1.3 $ 0.2 $ 0.5 * Includes underwriting, general and administrative expenses.

Schedule IV-Reinsurance

Schedule IV-Reinsurance	12 Months Ended
	Dec. 31, 2023
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract]
Schedule IV-Reinsurance	Schedule IV — Reinsurance Direct Ceded to Assumed from Net Percentage of (in millions) Year Ended December 31, 2023 Life Insurance in Force $ 14.9 $ 12.4 $ — $ 2.5 — % Premiums: Life insurance $ 0.1 $ 0.1 $ — $ — — % Accident and health insurance 6.7 6.5 — 0.2 — % Total earned premiums $ 6.8 $ 6.6 $ — $ 0.2 — % Benefits: Life insurance $ 0.7 $ 0.7 $ — $ — — % Accident and health insurance 32.0 31.9 — 0.1 — % Total policyholder benefits $ 32.7 $ 32.6 $ — $ 0.1 — % Year Ended December 31, 2022 Life Insurance in Force $ 16.7 $ 13.7 $ — $ 3.0 — % Premiums: Life insurance $ 0.2 $ 0.2 $ — $ — — % Accident and health insurance 7.2 6.9 — 0.3 — % Total earned premiums $ 7.4 $ 7.1 $ — $ 0.3 — % Benefits: Life insurance $ 0.5 $ 0.5 $ — $ — — % Accident and health insurance 31.2 30.7 — 0.5 — % Total policyholder benefits $ 31.7 $ 31.2 $ — $ 0.5 — % Year Ended December 31, 2021 Life Insurance in Force $ 29.5 $ 15.8 $ — $ 13.7 — % Premiums: Life insurance $ 0.8 $ 0.7 $ — $ 0.1 — % Accident and health insurance 7.9 7.5 — 0.4 — % Total earned premiums $ 8.7 $ 8.2 $ — $ 0.5 — % Benefits: Life insurance $ 1.4 $ 1.3 $ — $ 0.1 — % Accident and health insurance 31.0 30.9 — 0.1 — % Total policyholder benefits $ 32.4 $ 32.2 $ — $ 0.2 — %

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). Amounts are presented in United States of America ("U.S.") dollars and all amounts are in millions, except for number of shares, per share amounts and number of loans.
Use of Estimates	Use of Estimates The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts. The items affected by the use of estimates include but are not limited to, investments, reinsurance recoverables, other assets, future policy benefits and expenses, unearned premiums, claims and benefits payable, deferred gain on disposal of businesses, and commitments and contingencies. The estimates are sensitive to market conditions, investment yields, mortality, morbidity, commissions and other acquisition expenses, policyholder behavior and other factors. Actual results could differ from the estimates recorded. The Company believes all amounts reported are reasonable and adequate.
Fair Value	Fair Value
Investments	Investments Fixed maturity securities are classified as available-for-sale as defined in the investments guidance and are reported at fair value. If the fair value is higher than the amortized cost for fixed maturity securities, the excess is an unrealized gain; and, if lower than amortized cost, the difference is an unrealized loss. Net unrealized gains and losses on securities classified as available-for-sale, less deferred income taxes, are included in AOCI. Presentation of credit-related impairments is shown as an allowance, recognizing credit impairments upon purchase of securities as applicable, and requiring reversals of previously recognized credit-related impairments when applicable. For available for sale fixed maturity securities in an unrealized loss position for which the Company does not intend to sell or for which it is more likely than not that the Company would not be required to sell before an anticipated recovery in value, the Company evaluates whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost basis, changes to the credit rating of the security by a nationally recognized statistical ratings organization and any adverse conditions specifically related to the security, industry or geographic area, among other factors. If this assessment indicates a potential credit loss may exist, the present value of cash flows expected to be collected are compared to the security’s amortized cost basis. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit-related impairment exists, and a charge to income and an associated allowance for credit losses is recorded for the credit-related impairment. Any impairment not related to credit losses is recorded through other comprehensive income. The amount of the allowance for credit losses is limited to the amount by which fair value is less than the amortized cost basis. Upon recognizing a credit-related impairment, the cost basis of the security is not adjusted. Subsequent changes in the allowance for credit losses are recorded as provision for, or reversal of, credit loss expense. For fixed maturities where the Company records a credit loss, a determination is made as to the cause of the impairment and whether the Company expects a recovery in the value. Write-offs are charged against the allowance when management concludes the financial asset is uncollectible. For fixed maturities where the Company expects a recovery in value, the effective yield method is utilized, and the investment is amortized to par. For available for sale fixed maturity securities that the Company intends to sell, or for which it is more likely than not that the Company will be required to sell before recovery of its amortized cost basis, the entire impairment loss, or difference between the fair value and amortized cost basis of the security, is recognized in net realized gains (losses). The new cost basis of the security is the previous amortized cost basis less the impairment recognized and is not adjusted for any subsequent recoveries in fair value. The Company reports receivables for accrued investment income separately from fixed maturities available for sale and elected not to measure allowances for credit losses for accrued investment income as uncollectible balances are written off in a timely manner. Accrued investment income is included in other assets. Short-term investments include securities and other investments with durations of one year or less, but greater than three months, between the date of purchase and maturity. These amounts are reported at cost or amortized cost, which approximates fair value. Realized gains and losses on sales of investments are recognized on the specific identification basis. Investment income is recorded as earned and reported net of investment expenses.
Cash and Cash Equivalents	Cash and Cash Equivalents
Reinsurance	Reinsurance For ceded reinsurance, risk transfer requirements must be met for reinsurance accounting to apply. If risk transfer requirements are not met, the contract is accounted for as a deposit, resulting in the recognition of cash flows under the contract through a deposit asset or liability and not as revenue or expense. To meet risk transfer requirements, a reinsurance contract must include both insurance risk, consisting of both underwriting and timing risk, and a reasonable possibility of a significant loss for the assuming entity. Similar risk transfer criteria are used to determine whether directly written insurance contracts should be accounted for as insurance or as a deposit. Reinsurance recoverables include amounts related to paid benefits and estimated amounts related to unpaid policy and contract claims, future policyholder benefits and policyholder contract deposits. The cost of reinsurance is recognized as a reduction to premiums earned over the terms of the underlying reinsured policies. Amounts recoverable from reinsurers are estimated in a manner consistent with claim and claim adjustment expense reserves or future policy benefits reserves and are reported in the balance sheets. The cost of reinsurance related to long-duration contracts is recognized over the life of the underlying reinsured policies. The ceding of insurance does not discharge the Company’s primary liability to insureds, thus a credit exposure exists to the extent that any reinsurer is unable to meet the obligation assumed in the reinsurance agreements. To mitigate this exposure to reinsurer insolvencies, the Company evaluates the financial condition of its reinsurers and typically holds collateral (in the form of funds withheld, trusts and letters of credit) as security under the reinsurance agreements. The Company accounts for credit losses using the expected credit loss model for reinsurance recoverables. The Company uses a probability of default and loss given default methodology in estimating the allowance, whereby the credit ratings of reinsurers are used in determining the probability of default. The allowance is established for reinsurance recoverables on paid and unpaid future policy benefits and claims and benefits. Prior to applying default factors, the net exposure to credit risk is reduced for any collateral for which the right of offset exists, such as funds withheld, assets held in trust and letters of credit, which are part of the reinsurance arrangements, with adjustments to include consideration of credit exposure on the collateral. The methodology used by the Company incorporates historical default factors for each reinsurer based on their credit rating using comparably rated bonds as published by a major ratings service. The allowance is based upon the Company’s ongoing review of amounts outstanding, length of collection periods, changes in reinsurer credit standing and other relevant factors.
Other Assets	Other Assets Other assets include prepaid items, deferred income tax assets and accrued investment income.
Separate Accounts	Separate Accounts Assets and liabilities associated with separate accounts relate to premium and annuity considerations for variable annuity products for which the contract-holder, rather than the Company, bears the investment risk. Separate account assets (with matching liabilities) are reported at fair value. Revenues and expenses related to the separate account assets and liabilities, to the extent of benefits paid or provided to the separate account policyholders, are excluded from the amounts reported in the accompanying statements of operations because the underlying accounts involve investment-type annuity contracts and/or are subject to reinsurance.
Reserves	Reserves Reserves are established using generally accepted actuarial methods and reflect judgments about expected future premium and claim payments. Factors used in their calculation include experience derived from historical claim payments, expected future premiums and actuarial assumptions. Calculations incorporate assumptions about the incidence of incurred claims, the extent to which all claims have been reported, reporting lags, expenses, inflation rates, future investment earnings, internal claims processing costs and other relevant factors. The estimation of reserves includes an element of uncertainty given that management is using historical information and methods to project future events and reserve outcomes. The recorded reserves represent the Company’s best estimate at a point in time of the ultimate costs of settlement and administration of a claim or group of claims based upon actuarial assumptions and projections using facts and circumstances known at the time of calculation. The adequacy of reserves may be impacted by future trends in claims severity, frequency, judicial theories of liability and other factors. These variables are affected by both external and internal events, including: changes in the economic cycle, inflation, judicial trends, legislative changes and claims handling procedures. Many of these items are not directly quantifiable and not all future events can be anticipated when reserves are established. Reserve estimates are refined as experience develops. Adjustments to reserves, both positive and negative, are reflected in the statement of operations in the period in which such estimates are updated. Because establishment of reserves is an inherently complex process involving significant judgment and estimates, there can be no certainty that future settlement amounts for claims incurred through the financial reporting date will not vary from reported claims reserves. Future loss development could require reserves to be increased or decreased, which could have a material effect on the Company’s earnings in the periods in which such increases or decreases are made. However, based on information currently available, the Company believes its reserve estimates are adequate. Long Duration Contracts The Company adopted the targeted improvements accounting guidance for long-duration insurance contracts as of January 1, 2023, using a modified retrospective method on liabilities for future policy benefits and expenses to January 1, 2021 for long-term care insurance contracts that have been fully reinsured. Under the transition guidance, the long-term care insurance contracts are grouped into cohorts based on the contract’s issue year. Premiums are recognized when due as net earned premiums in the statement of operations. A future policy benefits and expenses reserve is recorded as the present value of estimated future policy benefits and expenses less the present value of estimated future net premiums. The net premium ratio (“NPR”) approach is used to recognize a liability when expected insurance benefits are accrued over the life of the contract in proportion to premium revenue. Policy expense assumptions are locked in as of December 31, 2020 as the long-term care insurance products are in run-off as of the transition date. Actual premiums and benefits are recognized on a quarterly basis in the statement of operations allocated in proportion to prior period cash flow projections at the cohort level. The updated cash flows used in the calculation are discounted using the discount rate used in the last premium deficiency test update prior to December 31, 2020 (the “original discount rate”) and presented as interest expense in the statement of operations. The revised NPR is used to measure benefit expense based on the recognized premium revenue in the period. The difference between the updated future policy benefits and expenses reserve opening period and previous ending period due to updating the NPR is presented as a remeasurement gain or loss (e.g., a cumulative catch-up adjustment) in policyholder benefits in the Company’s statements of operations. A remeasurement of the ending reporting period future policy benefits and expenses reserve is calculated using the current upper medium grade fixed-income corporate bond instrument yield as of the balance sheet ending period (the “current discount rate”). The current discount rate used is an externally published US corporate A index weighted average spot rate that is updated quarterly and effectively matches the duration of the expected cash flow streams of the long-term care reserves. The difference between the ending period future policy benefits and expenses reserve measured using the original discount rate and the future policy benefits and expenses reserve measured using the current discount rate is recorded in AOCI in the Company’s statements of comprehensive income. The long-term care insurance contracts are fully reinsured and there is no impact to stockholders’ equity or net income as the reserves are fully reinsured. See Note 10 for additional information. Short Duration Contracts The Company’s short duration contracts include group insurance contracts no longer offered, as well as credit life, disability and mortgage accidental death contracts. For short duration contracts, claims and benefits payable reserves are recorded when insured events occur. The liability is based on the expected ultimate cost of settling the claims. The claims and benefits payable reserves include: (1) case reserves for known but unpaid claims as of the balance sheet date; (2) incurred but not reported (“IBNR”) reserves for claims where the insured event has occurred but has not been reported to the Company as of the balance sheet date; and (3) loss adjustment expense reserves for the expected handling costs of settling the claims. Factors used in the calculation include experience derived from historical claim payments and actuarial assumptions including loss development factors and expected loss ratios. Changes in the estimated liabilities are recorded as a charge or credit to policyholder benefits as estimates are updated.
Contingencies	Contingencies A loss contingency is recorded if reasonably estimable and probable. The Company establishes reserves for these contingencies at the best estimate, or if no one estimated amount within the range of possible losses is more probable than any other, the Company records an estimated reserve at the low end of the estimated range. Contingencies affecting the Company primarily relate to legal and regulatory matters, which are inherently difficult to evaluate and are subject to significant changes.
Premiums	Premiums Long Duration Contracts Premiums for long term care insurance and life insurance contracts no longer offered are recognized as revenue when due from the policyholder. For investment-type annuity contracts, revenues consist of charges assessed against policy balances. Short Duration Contracts The Company’s short duration contracts revenue is recognized
Underwriting, General and Administrative Expenses	Underwriting, General and Administrative Expenses Underwriting, general and administrative expenses consist primarily of commissions, premium taxes, licenses, fees, salaries and personnel benefits, and other general operating expenses and are expensed as incurred.
Income Taxes	Income Taxes The Company reports its taxable income in a consolidated federal income tax return along with other affiliated subsidiaries of the Parent. Income tax expense or benefit is allocated among the affiliated subsidiaries by applying income tax rates to taxable income or loss determined on a separate return basis according to a tax allocation agreement. Entities with losses record current tax benefits to the extent such losses are utilized in the consolidated federal tax return. Current federal income taxes are recognized based upon amounts estimated to be payable or recoverable as a result of taxable operations for the current year. Deferred income taxes are recorded for temporary differences between the financial reporting basis and income tax basis of assets and liabilities, based on enacted tax laws and statutory tax rates applicable to the periods in which the Company expects the temporary differences to reverse. A valuation allowance is established for deferred tax assets when it is more likely than not that an amount will not be realized. The impact of changes in tax rates on all deferred tax assets and liabilities are required to be reflected within income on the enactment date, regardless of the financial statement component where the deferred tax originated. The Company classifies net interest expense related to tax matters and any applicable penalties as a component of income tax expense.
Comprehensive Income	Comprehensive Income Comprehensive income is comprised of net income, and net unrealized gains and losses on securities classified as available for sale, less deferred income taxes.
Recent Accounting Pronouncements - Adopted and Future Adoption of Accounting Pronouncements	Recent Accounting Pronouncements — Adopted Changes to GAAP are established by the Financial Accounting Standards Board ("FASB") in the form of Accounting Standards Updates ("ASUs") to the FASB Accounting Standards Codification. The Company considers the applicability and impact of all ASUs. The following tables provide a description of ASUs recently issued by the FASB and the impact of their adoption on the Company's financial statements. Adopted Accounting Pronouncements The table below describes the impacts of the ASUs adopted by the Company, effective January 1, 2023: Standard Summary of the Standard Effective date Method of Adoption Impact of the Standard on the Company's Financial Statements ASU 2018-12, The guidance includes the following primary changes: assumptions supporting liabilities for future policy benefits and expenses will no longer be locked-in but must be updated at least annually with the impact of changes to the liability reflected in earnings (except for discount rates); the discount rate assumptions will be based on upper-medium grade (low credit risk) fixed-income instrument yield instead of the earnings rate of invested assets; the discount rate must be evaluated at each reporting date and the impact of changes to the liability estimate as a result of updating the discount rate assumption is required to be recognized in other comprehensive income; the provision for adverse deviation is eliminated; and premium deficiency testing is eliminated. Other noteworthy changes include the following: differing models for amortizing deferred acquisition costs will become uniform for all long-duration In December 2022, the FASB issued guidance to provide January 1, 2023, to be The Company adopted this standard The adoption of this standard along Future Adoption of Accounting Pronouncements ASUs not listed below were assessed and either determined to be not applicable or are not expected to have a material impact on the Company's financial statements or disclosures. ASUs issued but not yet adopted as of December 31, 2023, that are currently being assessed and may or may not have a material impact on the Company's financial statements or disclosures are included. Standard Summary of the Standard Effective date Method of Adoption Impact of the Standard on the Company's Financial Statements ASU 2023-09 Income The guidance improves the transparency of income tax January 1, 2025 (with early adoption permitted for annual financial statements that have not yet been issued or made available for issuance). The Company is assessing when the

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Schedule of Reserve Information of the Company’s Major Product Lines	The following table provides reserve information for our major product lines for the years ended December 31, 2023 and 2022: December 31, 2023 December 31, 2022 Claims and Benefits Payable Claims and Benefits Payable Future Unearned Case Incurred Future Unearned Case Incurred Long Duration Contracts: Universal life and other products no longer offered $ — $ — $ 0.4 $ — $ — $ — $ 0.4 $ — Disposed and run-off businesses 420.9 1.9 — — 434.9 2.0 — — Short Duration Contracts: Disposed and run-off businesses — — 15.1 0.2 — — 16.5 0.2 Total $ 420.9 $ 1.9 $ 15.5 $ 0.2 $ 434.9 $ 2.0 $ 16.9 $ 0.2 The following table provides a roll forward of the Company’s beginning and ending claims and benefits payable balances. Claims and benefits payable is the liability for unpaid loss and loss adjustment expenses and are comprised of case and IBNR reserves. Since unpaid loss and loss adjustment expenses are estimates, the Company’s actual losses incurred may be more or less than the Company’s previously developed estimates, which is referred to as either unfavorable or favorable development, respectively. The best estimate of ultimate loss and loss adjustment expenses is generally selected from a blend of methods that are applied consistently each period. There have been no significant changes in the methodologies and assumptions utilized in estimating the liability for unpaid loss and loss adjustment expenses for any of the periods presented. Years Ended December 31, 2023 2022 2021 Claims and benefits payable, at beginning of year $ 17.1 $ 19.1 $ 22.5 Less: Reinsurance ceded and other (17.0) (19.0) (22.4) Net claims and benefits payable, at beginning of year 0.1 0.1 0.1 Incurred losses and loss adjustment expenses related to: Current Year 0.9 0.1 0.3 Prior years (0.8) — — Total incurred losses and loss adjustment expenses 0.1 0.1 0.3 Paid losses and loss adjustment expenses related to: Current year 0.1 0.1 0.2 Prior years — — 0.1 Total paid losses and loss adjustment expenses 0.1 0.1 0.3 Net claims and benefits payable, at end of year 0.1 0.1 0.1 Plus: Reinsurance ceded and other 15.6 17.0 19.0 Claims and benefits payable, at end of year $ 15.7 $ 17.1 $ 19.1
Summary of Impact of Adoption	The table below describes the impacts of the ASUs adopted by the Company, effective January 1, 2023: Standard Summary of the Standard Effective date Method of Adoption Impact of the Standard on the Company's Financial Statements ASU 2018-12, The guidance includes the following primary changes: assumptions supporting liabilities for future policy benefits and expenses will no longer be locked-in but must be updated at least annually with the impact of changes to the liability reflected in earnings (except for discount rates); the discount rate assumptions will be based on upper-medium grade (low credit risk) fixed-income instrument yield instead of the earnings rate of invested assets; the discount rate must be evaluated at each reporting date and the impact of changes to the liability estimate as a result of updating the discount rate assumption is required to be recognized in other comprehensive income; the provision for adverse deviation is eliminated; and premium deficiency testing is eliminated. Other noteworthy changes include the following: differing models for amortizing deferred acquisition costs will become uniform for all long-duration In December 2022, the FASB issued guidance to provide January 1, 2023, to be The Company adopted this standard The adoption of this standard along Future Adoption of Accounting Pronouncements ASUs not listed below were assessed and either determined to be not applicable or are not expected to have a material impact on the Company's financial statements or disclosures. ASUs issued but not yet adopted as of December 31, 2023, that are currently being assessed and may or may not have a material impact on the Company's financial statements or disclosures are included. Standard Summary of the Standard Effective date Method of Adoption Impact of the Standard on the Company's Financial Statements ASU 2023-09 Income The guidance improves the transparency of income tax January 1, 2025 (with early adoption permitted for annual financial statements that have not yet been issued or made available for issuance). The Company is assessing when the

Allowance for Credit Losses (Ta

Allowance for Credit Losses (Tables)	12 Months Ended
	Dec. 31, 2023
Credit Loss [Abstract]
Summary of Changes in CECL Allowance for Reinsurance Recoverables	The following table presents the changes in the allowance for credit losses for reinsurance recoverables for the periods indicated: Total Balance, December 31, 2021 $ 0.3 Current period change for credit losses 0.2 Balance, December 31, 2022 0.5 Current period change for credit losses $ (0.2) Balance, December 31, 2023 $ 0.3

Investments (Tables)

Investments (Tables)	12 Months Ended
	Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Schedule of Cost or Amortized Cost, Gross Unrealized Gains and Losses, Fair Value and Other-than-Temporary Impairment (OTTI) of Fixed Maturity and Equity Securities	The following tables show the cost or amortized cost, gross unrealized gains and losses, and fair value of the Company's fixed maturity securities as of the dates indicated: December 31, 2023 Cost or Gross Gross Fair Value Fixed maturity securities: U.S. government and government agencies and authorities $ 1.9 $ — $ (0.1) $ 1.8 States, municipalities and political subdivisions 0.5 — — 0.5 Foreign governments 0.2 — — 0.2 Asset backed securities 0.1 — — 0.1 Residential mortgage-backed 4.8 — (0.7) 4.1 U.S. corporate 2.1 0.1 — 2.2 Foreign corporate 0.4 — — 0.4 Total fixed maturity securities $ 10.0 $ 0.1 $ (0.8) $ 9.3 December 31, 2022 Cost or Gross Gross Fair Value Fixed maturity securities: U.S. government and government agencies and authorities $ 1.9 $ — $ (0.2) $ 1.7 States, municipalities and political subdivisions 0.5 — — 0.5 Foreign governments 0.3 — — 0.3 Residential mortgage-backed 5.3 — (0.8) 4.5 U.S. corporate 1.9 — — 1.9 Foreign corporate 0.3 — — 0.3 Total fixed maturity securities $ 10.2 $ — $ (1.0) $ 9.2
Schedule of Cost or Amortized Cost and Fair Value of Fixed Maturity Securities by Contractual Maturity	The cost or amortized cost and fair value of fixed maturity securities at December 31, 2023 by contractual maturity are shown below. Actual maturities may differ from contractual maturities because issuers of the securities may have the right to call or prepay obligations with or without call or prepayment penalties. December 31, 2023 Cost or Fair Due in one year or less $ 2.0 $ 2.0 Due after one year through five years 1.8 1.7 Due after five years through ten years 1.3 1.4 Due after ten years — — Total 5.1 5.1 Asset backed securities 0.1 0.1 Residential mortgage-backed 4.8 4.1 Total $ 10.0 $ 9.3
Schedule of Major Categories of Investment Income	The following table shows the major categories of net investment income for the periods indicated: Years Ended December 31, 2023 2022 2021 Fixed maturity securities $ 0.3 $ 1.3 $ 1.4 Short term investments 0.1 — — Total investment income 0.4 1.3 1.4 Investment expenses — — (0.1) Net investment income $ 0.4 $ 1.3 $ 1.3
Summary of Proceeds from Sales of Available-for-Sale Securities and the Gross Realized gains and Gross Realized Losses	The following table summarizes the proceeds from sales of available-for-sale fixed maturities and the gross realized gains and gross realized losses that have been recognized in the statement of operations as a result of those sales for the periods indicated: Years Ended December 31, 2023 2022 2021 Proceeds from sales $ — $ 29.4 $ 9.1 Gross realized gains — 0.7 0.2 Gross realized losses — (1.8) — Net realized gains (losses) from sales of fixed maturity securities $ — $ (1.1) $ 0.2
Schedule of Net Realized Gains (Losses) Recognized in the Statement of Operations	The following table sets forth the net realized gains (losses) recognized in the statement of operations for the periods indicated: Years Ended December 31, 2023 2022 2021 Net realized gains (losses) related to sales: Net realized gains (losses) from sales of fixed maturity securities $ — $ (1.1) $ 0.2

Fair Value Disclosures (Tables)

Fair Value Disclosures (Tables)	12 Months Ended
	Dec. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of the Company's Fair Value Hierarchy for Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following tables present the Company's fair value hierarchy for assets and liabilities measured at fair value on a recurring basis as of December 31, 2023 and 2022. The amounts presented below for cash equivalents and assets held in and liabilities related to separate accounts differ from the amounts presented in the balance sheet because only certain investments or certain assets and liabilities within these line items are measured at estimated fair value. The fair value amount and the majority of the associated levels presented for assets and liabilities held in separate accounts are received directly from third parties. December 31, 2023 Total Level 1 Level 2 Level 3 Financial Assets Fixed maturity securities: U.S. government and government agencies and authorities $ 1.8 $ — $ 1.8 $ — States, municipalities and political subdivisions 0.5 — 0.5 — Foreign governments 0.2 — 0.2 — Asset-backed 0.1 — 0.1 — Residential mortgage-backed 4.1 — 4.1 — U.S. corporate 2.2 — 2.2 — Foreign corporate 0.4 — 0.4 — Short-term investments 1.6 1.6 (1) — — Cash equivalents 0.7 0.7 (1) — — Assets held in separate accounts 10.2 6.0 (2) 4.2 (3) — Total financial assets $ 21.8 $ 8.3 $ 13.5 $ — Financial Liabilities Liabilities related to separate accounts $ 10.2 $ 6.0 (2) $ 4.2 (3) $ — December 31, 2022 Total Level 1 Level 2 Level 3 Financial Assets Fixed maturity securities: U.S. government and government $ 1.8 $ — $ 1.8 $ — States, municipalities and political subdivisions 0.5 — 0.5 — Foreign governments 0.2 — 0.2 — Residential mortgage-backed 4.5 — 4.5 — U.S. corporate 1.9 — 1.9 — Foreign corporate 0.3 — 0.3 — Short-term investments 1.6 1.6 (1) — — Cash equivalents 0.1 0.1 (1) — — Assets held in separate accounts 10.1 4.8 (2) 5.3 (3) — Total financial assets $ 21.0 $ 6.5 $ 14.5 $ — Financial Liabilities Liabilities related to separate accounts $ 10.1 $ 4.8 (2) $ 5.3 (3) $ — (1) Primarily includes money market funds. (2) Primarily includes mutual funds and related obligations. (3) Primarily includes fixed maturity securities and related obligations.
Schedule of Carrying Value, Fair Value Amount and Hierarchy Level of the Financial Instruments That Are Not Recognized or Are Not Carried at Fair Value	The following tables disclose the carrying value, fair value and hierarchy level of the financial instruments that are not recognized or are not carried at fair value in the balance sheet as of the dates indicated: December 31, 2023 Fair Value Carrying Total Level 1 Level 2 Level 3 Financial Liabilities Policy reserves under investment products $ 4.8 $ 5.3 $ — $ — $ 5.3 December 31, 2022 Fair Value Carrying Total Level 1 Level 2 Level 3 Financial Liabilities Policy reserves under investment products (Individual and group annuities, subject to discretionary withdrawal) (1) $ 4.9 $ 5.1 $ — $ — $ 5.1 (1) Only the fair value of the Company's policy reserves for investment-type contracts (those without significant mortality or morbidity risk) are reflected in the table above.

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Schedule of Company's Current and Deferred Federal Tax Expense (Benefit)	The components of income tax expense (benefit) were as follows for the periods indicated: Years Ended December 31, 2023 2022 2021 Current expense $ (0.2) $ 0.3 $ 0.3 Deferred expense (benefit) 0.2 (0.5) — Total income tax expense $ — $ (0.2) $ 0.3
Schedule of Reconciliation of Federal Income Tax Rate to the Company’s Effective Income Tax Rate	A reconciliation of the federal income tax rate to the Company's effective income tax rate follows: December 31, 2023 2022 2021 Federal income tax rate: 21.0 % 21.0 % 21.0 % Reconciling items: Tax exempt interest (2.5) 0.6 (1.3) Dividend received deduction (2.1) 0.5 (0.3) Other (0.8) (0.3) — Effective income tax rate: 15.6 % 21.8 % 19.4 %
Schedule of Significant Deferred Tax Assets and Deferred Tax Liabilities	The tax effects of temporary differences that result in deferred tax assets and deferred tax liabilities are as follows: December 31, 2023 2022 Deferred tax assets Deferred acquisition costs $ 1.6 $ 1.6 Deferred gain on disposal of business 0.1 0.1 Investments, net 0.2 0.3 Net unrealized appreciation on securities 0.2 0.2 Other 0.2 0.3 Total deferred tax assets 2.3 2.5 Deferred tax liabilities Net unrealized appreciation on securities — — Total deferred tax liabilities — — Net deferred income tax assets $ 2.3 $ 2.5

Statutory Information (Tables)

Statutory Information (Tables)	12 Months Ended
	Dec. 31, 2023
Insurance [Abstract]
Schedule of Reconciliations of Net Income and Stockholder's Equity	Reconciliations of net income and stockholder’s equity on the basis of statutory accounting to the related amounts presented in the accompanying statements were as follows: Net Income Stockholder's Equity 2023 2022 2021 2023 2022 Based on SAP $ (1.0) $ (0.1) $ 1.1 $ 10.8 $ 11.8 Policy and claim reserves 1.1 — — 1.1 — Investment valuation difference — — (0.1) (0.7) (1.0) Current income taxes (0.2) — — (0.2) — Deferred taxes (0.2) 0.5 — 0.3 0.4 Deferred gain on disposal of businesses and gains on disposal of businesses — — 0.1 (0.4) (0.6) Other differences 0.5 (1.0) 0.1 1.2 1.2 Based on GAAP $ 0.2 $ (0.6) $ 1.2 $ 12.1 $ 11.8

Reinsurance (Tables)

Reinsurance (Tables)	12 Months Ended
	Dec. 31, 2023
Reinsurance Disclosures [Abstract]
Schedule of Reinsurance Recoverables	The following table provides details of the reinsurance recoverables balance as of the dates indicated: 2023 2022 Ceded future policyholder benefits and expense $ 335.0 $ 348.6 Ceded unearned premium 1.9 2.0 Ceded claims and benefits payable 100.6 101.8 Ceded paid losses (0.2) 0.3 Total $ 437.3 $ 452.7
Schedule of Reinsurance Recoverable	The following table provides the reinsurance recoverable as of December 31, 2023 grouped by A.M. Best financial strength ratings: A.M. Best ratings of Ceded future Ceded unearned Ceded claims Ceded paid Total A++ or A+ $ 330.1 $ 1.9 $ 100.6 $ 0.1 $ 432.7 B++ or B+ 4.9 — — — 4.9 Total 335.0 1.9 100.6 0.1 437.6 Less: Allowance — — — (0.3) (0.3) Total Reinsurance recoverable $ 335.0 $ 1.9 $ 100.6 $ (0.2) $ 437.3 The following table presents the reinsurance recoverable from John Hancock, Sun Life, Talcott Resolution, and other reinsurers as of December 31, 2023 and 2022. Years Ended December 31, Reinsurer 2023 2022 John Hancock $ 416.1 $ 430.0 Sun Life 16.1 17.4 Talcott Resolution 4.7 4.9 Other reinsurers 0.4 0.4 Total $ 437.3 $ 452.7
Schedule of Effect of Reinsurance on Premiums Earned and Benefits Incurred	The effect of reinsurance on premiums earned and benefits incurred was as follows for the period indicated: Years Ended December 31, 2023 2022 2021 Long Short Total Long Short Total Long Short Total Direct earned premiums $ 6.5 $ 0.3 $ 6.8 $ 7.0 $ 0.4 $ 7.4 $ 8.1 $ 0.6 $ 8.7 Premiums ceded (6.5) (0.1) (6.6) (7.0) (0.1) (7.1) (8.1) (0.1) (8.2) Net earned premiums $ — $ 0.2 $ 0.2 $ — $ 0.3 $ 0.3 $ — $ 0.5 $ 0.5 Direct policyholder benefits $ 31.4 $ 1.3 $ 32.7 $ 30.3 $ 1.4 $ 31.7 $ 31.9 $ 0.5 $ 32.4 Policyholder benefits ceded (31.4) (1.2) (32.6) (30.3) (0.9) (31.2) (31.9) (0.3) (32.2) Net policyholder benefits $ — $ 0.1 $ 0.1 $ — $ 0.5 $ 0.5 $ — $ 0.2 $ 0.2

Reserves (Tables)

Reserves (Tables)	12 Months Ended
	Dec. 31, 2023
Insurance [Abstract]
Schedule of Reserve Information of the Company’s Major Product Lines	The following table provides reserve information for our major product lines for the years ended December 31, 2023 and 2022: December 31, 2023 December 31, 2022 Claims and Benefits Payable Claims and Benefits Payable Future Unearned Case Incurred Future Unearned Case Incurred Long Duration Contracts: Universal life and other products no longer offered $ — $ — $ 0.4 $ — $ — $ — $ 0.4 $ — Disposed and run-off businesses 420.9 1.9 — — 434.9 2.0 — — Short Duration Contracts: Disposed and run-off businesses — — 15.1 0.2 — — 16.5 0.2 Total $ 420.9 $ 1.9 $ 15.5 $ 0.2 $ 434.9 $ 2.0 $ 16.9 $ 0.2 The following table provides a roll forward of the Company’s beginning and ending claims and benefits payable balances. Claims and benefits payable is the liability for unpaid loss and loss adjustment expenses and are comprised of case and IBNR reserves. Since unpaid loss and loss adjustment expenses are estimates, the Company’s actual losses incurred may be more or less than the Company’s previously developed estimates, which is referred to as either unfavorable or favorable development, respectively. The best estimate of ultimate loss and loss adjustment expenses is generally selected from a blend of methods that are applied consistently each period. There have been no significant changes in the methodologies and assumptions utilized in estimating the liability for unpaid loss and loss adjustment expenses for any of the periods presented. Years Ended December 31, 2023 2022 2021 Claims and benefits payable, at beginning of year $ 17.1 $ 19.1 $ 22.5 Less: Reinsurance ceded and other (17.0) (19.0) (22.4) Net claims and benefits payable, at beginning of year 0.1 0.1 0.1 Incurred losses and loss adjustment expenses related to: Current Year 0.9 0.1 0.3 Prior years (0.8) — — Total incurred losses and loss adjustment expenses 0.1 0.1 0.3 Paid losses and loss adjustment expenses related to: Current year 0.1 0.1 0.2 Prior years — — 0.1 Total paid losses and loss adjustment expenses 0.1 0.1 0.3 Net claims and benefits payable, at end of year 0.1 0.1 0.1 Plus: Reinsurance ceded and other 15.6 17.0 19.0 Claims and benefits payable, at end of year $ 15.7 $ 17.1 $ 19.1
Liability for Future Policy Benefit, Activity	The following table presents the balances and changes in the long-term care future policy benefits and expense reserve: Years Ended December 31, 2023 2022 2021 Present value of expected net premiums Balance, beginning of period $ 34.2 $ 37.1 $ 44.4 Beginning balance at original discount rate 33.4 29.2 33.7 Effect of changes in cash flow assumptions (1) 1.5 9.4 (3.2) Effect of actual variances from expected experience 3.5 (2.7) (2.4) Adjusted beginning of period balance 38.4 35.9 28.1 Experience variance (2) — (0.3) 2.4 Interest accrual 2.8 4.6 6.0 Net premiums collected (4.7) (6.8) (7.3) Ending balance at original discount rate 36.5 33.4 29.2 Effect of changes in discount rate assumptions (0.1) 0.8 7.9 Balance, end of period $ 36.4 $ 34.2 $ 37.1 Present value of expected future policy benefits Balance, beginning of period $ 462.4 $ 658.5 $ 683.2 Beginning balance at original discount rate 444.4 430.0 421.7 Effect of changes in cash flow assumptions (1) — 12.3 (1.2) Effect of actual variances from expected experience 4.4 (3.3) (2.7) Adjusted beginning of period balance 448.8 439.0 417.8 Experience variance (2) 1.0 (1.2) (0.4) Interest accrual 19.5 24.7 29.3 Benefit payments (16.3) (18.1) (16.7) Ending balance at original discount rate 453.0 444.4 430.0 Effect of changes in discount rate assumptions (2.4) 18.0 228.5 Balance, end of period $ 450.6 $ 462.4 $ 658.5 Net future policy benefits and expenses $ 414.2 $ 428.2 $ 621.4 Related reinsurance recoverable 414.2 428.2 621.4 Net future policy benefits and expenses, after reinsurance recoverable $ — $ — $ — Weighted-average liability duration of the future policy benefits and expenses (in years) 12.0 12.7 13.0 (1) The increase for the years ending December 31, 2023 and 2022 was primarily due to historical experience reflecting a decreasing trend in lapse and mortality rates on the long-term care insurance products. The decrease for the years ending December 31, 2021 was primarily due to reduced expense assumptions. (2) Experience variance includes adverse development resulting from the allocation of the premium deficiency reserve to the cohort level for the issue years where net premiums exceed gross premiums. The following table presents the amount of undiscounted expected future benefit payments and expected gross premiums for the long-term care insurance contracts: December 31, 2023 December 31, 2022 Expected future benefits payments $ 829.3 $ 850.0 Expected future gross premiums $ 69.4 $ 76.2 The following table presents the amount of long-term care revenue and interest recognized in the statements of operations: Years Ended December 31, 2023 2022 2021 Gross premiums $ 1.5 $ 1.7 $ 1.9 Interest expense (original discount rate) $ 5.6 $ 4.7 $ 5.1 The following table presents the weighted-average interest rate for long-term care insurance contracts: December 31, 2023 December 31, 2022 Interest expense (original discount rate) 5.95 % 5.95 % Current discount rate 6.01 % 5.52 % The following table illustrates the impact of adoption on the long-term care insurance contracts: Future Policy Benefits and Expenses, pre-adoption December 31, 2020 $ 386.4 Effect of the remeasurement of the liability at current discount rate 250.8 Adjustment for loss contracts with NPR in excess of 100% under the modified retrospective approach 1.6 Adjusted balance, beginning of January 1, 2021 638.8 Less: reinsurance recoverable (638.8) Future Policy Benefits and Expenses, beginning of year January 1, 2021, net of reinsurance $ — The following table presents the effect of transition adjustments on stockholders' equity: January 1, 2021 Retained Earnings Accumulated Other Comprehensive Loss $ (1.6) $ (250.8)
Policyholder Account Balance And Liability For Unpaid Claims And Claims Adjustment Expense	The following table presents a reconciliation of the long-term care net future policy benefits and expenses to the future policy benefits and expenses reserve in the balance sheet: December 31, 2023 December 31, 2022 Long-term care $ 414.2 $ 428.2 Other 6.7 6.7 Total $ 420.9 $ 434.9

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Tables)	12 Months Ended
	Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Components of Accumulated Other Comprehensive Income, Net of Tax	Certain amounts included in the statement of comprehensive income are net of reclassification adjustments. The following tables summarize those reclassification adjustments (net of taxes) for the periods indicated: Year Ended December 31, 2023 Accumulated Balance at December 31, 2022 $ (0.7) Change in accumulated other comprehensive income (loss) before reclassifications 0.1 Amounts reclassified from accumulated other comprehensive income (loss) — Net current-period other comprehensive income (loss) 0.1 Balance at December 31, 2023 $ (0.6) Year Ended December 31, 2022 Accumulated Balance at December 31, 2021 $ 2.2 Change in accumulated other comprehensive income (loss) before reclassifications (3.8) Amounts reclassified from accumulated other comprehensive income (loss) 0.9 Net current-period other comprehensive income (loss) (2.9) Balance at December 31, 2022 $ (0.7) Year Ended December 31, 2021 Accumulated Balance at December 31, 2020 $ 3.4 Change in accumulated other comprehensive income (loss) before reclassifications $ (1.1) Amounts reclassified from accumulated other comprehensive income (loss) $ (0.1) Net current-period other comprehensive income (loss) $ (1.2) Balance at December 31, 2021 $ 2.2 (1) Accumulated other comprehensive income consists of net unrealized gains on securities.
Summary of the Reclassifications Out of Accumulated Other Comprehensive Income	The following tables summarize the reclassifications out of AOCI for the periods indicated: Details about AOCI components Amount reclassified from AOCI Affected line item in the statement Years Ended December 31, 2023 2022 2021 Net unrealized gains (losses) on securities $ — $ 1.1 $ (0.1) Net realized gains (losses) on investments Tax effect — (0.2) — Provision for income taxes Total reclassifications for the period $ — $ 0.9 $ (0.1) Net of tax

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future Policy Benefits and Expenses	$ 420.9	$ 434.9
Unearned Premiums	1.9	2
Case Reserves	15.5	16.9
Incurred But Not Reported Reserves	0.2	0.2
Universal life and other products no longer offered
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future Policy Benefits and Expenses	0	0
Unearned Premiums	0	0
Case Reserves	0.4	0.4
Incurred But Not Reported Reserves	0	0
Disposed and run-off businesses
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future Policy Benefits and Expenses	420.9	434.9
Unearned Premiums	1.9	2
Case Reserves	0	0
Incurred But Not Reported Reserves	0	0
Disposed and run-off businesses
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future Policy Benefits and Expenses	0	0
Unearned Premiums	0	0
Case Reserves	15.1	16.5
Incurred But Not Reported Reserves	$ 0.2	$ 0.2

Allowance for Credit Losses - N

Allowance for Credit Losses - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Financing Receivable, Allowance for Credit Loss [Line Items]
Reinsurance recoverable, allowance for credit loss	$ 0.3	$ 0.5	$ 0.3
Increase (decrease) in allowance for credit losses	(0.2)	0.2
Net reinsurance recoverable	$ 437.3	$ 452.7
Standard & Poor's, A- Rating Or Better
Financing Receivable, Allowance for Credit Loss [Line Items]
Financing receivable, credit quality, percentage	1	0.97
Standard & Poor's, BBB or BB Rating
Financing Receivable, Allowance for Credit Loss [Line Items]
Financing receivable, credit quality, percentage	0	0.03

Allowance for Credit Losses - C

Allowance for Credit Losses - Changes in CECL Allowance for Reinsurance Recoverables (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Reinsurance Recoverable, Allowance for Credit Loss [Roll Forward]
Beginning balance	$ 0.5	$ 0.3
Current period change for credit losses	(0.2)	0.2
Ending balance	$ 0.3	$ 0.5

Investments - Cost or Amortized

Investments - Cost or Amortized Cost, Gross Unrealized Gains and Losses, Fair Value (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Cost or Amortized Cost	$ 10	$ 10.2
Gross Unrealized Gains	0.1	0
Gross Unrealized Losses	(0.8)	(1)
Fair Value	9.3	9.2
U.S. government and government agencies and authorities
Debt Securities, Available-for-sale [Line Items]
Cost or Amortized Cost	1.9	1.9
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(0.1)	(0.2)
Fair Value	1.8	1.7
States, municipalities and political subdivisions
Debt Securities, Available-for-sale [Line Items]
Cost or Amortized Cost	0.5	0.5
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Fair Value	0.5	0.5
Foreign governments
Debt Securities, Available-for-sale [Line Items]
Cost or Amortized Cost	0.2	0.3
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Fair Value	0.2	0.3
Asset-backed
Debt Securities, Available-for-sale [Line Items]
Cost or Amortized Cost	0.1
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Fair Value	0.1
Residential mortgage-backed
Debt Securities, Available-for-sale [Line Items]
Cost or Amortized Cost	4.8	5.3
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(0.7)	(0.8)
Fair Value	4.1	4.5
U.S. corporate
Debt Securities, Available-for-sale [Line Items]
Cost or Amortized Cost	2.1	1.9
Gross Unrealized Gains	0.1	0
Gross Unrealized Losses	0	0
Fair Value	2.2	1.9
Foreign corporate
Debt Securities, Available-for-sale [Line Items]
Cost or Amortized Cost	0.4	0.3
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Fair Value	$ 0.4	$ 0.3

Investments - Cost, Amortized C

Investments - Cost, Amortized Cost, and Fair Value of Fixed Maturity Securities by Contractual Maturity (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Cost or Amortized Cost
Due in one year or less	$ 2
Due after one year through five years	1.8
Due after five years through ten years	1.3
Due after ten years	0
Total, single maturity	5.1
Cost or Amortized Cost	10	$ 10.2
Fair Value
Due in one year or less	2
Due after one year through five years	1.7
Due after five years through ten years	1.4
Due after ten years	0
Total, single maturity	5.1
Total	9.3	9.2
Residential mortgage-backed
Cost or Amortized Cost
Mortgage-backed	4.8
Cost or Amortized Cost	4.8	5.3
Fair Value
Mortgage-backed	4.1
Total	4.1	$ 4.5
Asset-backed
Cost or Amortized Cost
Mortgage-backed	0.1
Cost or Amortized Cost	0.1
Fair Value
Mortgage-backed	0.1
Total	$ 0.1

Investments - Categories of Net

Investments - Categories of Net Investment Income (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Major categories of net investment income
Total investment income	$ 0.4	$ 1.3	$ 1.4
Investment expenses	0	0	(0.1)
Net investment income	0.4	1.3	1.3
Fixed maturity securities
Major categories of net investment income
Total investment income	0.3	1.3	1.4
Short-term investments
Major categories of net investment income
Total investment income	$ 0.1	$ 0	$ 0

Investments - Proceeds from Ava

Investments - Proceeds from Available-for-Sale Securities (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Investments, Debt and Equity Securities [Abstract]
Proceeds from sales	$ 0	$ 29.4	$ 9.1
Gross realized gains	0	0.7	0.2
Gross realized losses	0	(1.8)	0
Net realized gains (losses) from sales of fixed maturity securities	$ 0	$ (1.1)	$ 0.2

Investments - Net Realized Gain

Investments - Net Realized Gains (Losses) Recognized in the Statement of Operations (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Net realized gains (losses) related to sales:
Net realized (losses) gains on investments	$ 0	$ (1.1)	$ 0.2

Investments - Narrative (Detail

Investments - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Fixed maturity securities on deposit with various governmental authorities	$ 0.8	$ 0.8

Fair Value Disclosures - Assets

Fair Value Disclosures - Assets and Liabilities (Details) - Recurring basis - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Level 1
Financial Assets
Financial assets	$ 8.3	$ 6.5
Financial Liabilities
Financial liabilities	6	4.8
Level 1 | Fixed maturity securities | U.S. government and government agencies and authorities
Financial Assets
Financial assets	0	0
Level 1 | Fixed maturity securities | States, municipalities and political subdivisions
Financial Assets
Financial assets	0	0
Level 1 | Fixed maturity securities | Foreign governments
Financial Assets
Financial assets	0	0
Level 1 | Fixed maturity securities | Asset-backed
Financial Assets
Financial assets	0
Level 1 | Fixed maturity securities | Residential mortgage-backed
Financial Assets
Financial assets	0	0
Level 1 | Fixed maturity securities | U.S. corporate
Financial Assets
Financial assets	0	0
Level 1 | Fixed maturity securities | Foreign corporate
Financial Assets
Financial assets	0	0
Level 1 | Short-term investments
Financial Assets
Financial assets	1.6	1.6
Level 1 | Cash equivalents
Financial Assets
Financial assets	0.7	0.1
Level 1 | Assets held in separate accounts
Financial Assets
Financial assets	6	4.8
Level 2
Financial Assets
Financial assets	13.5	14.5
Financial Liabilities
Financial liabilities	4.2	5.3
Level 2 | Fixed maturity securities | U.S. government and government agencies and authorities
Financial Assets
Financial assets	1.8	1.8
Level 2 | Fixed maturity securities | States, municipalities and political subdivisions
Financial Assets
Financial assets	0.5	0.5
Level 2 | Fixed maturity securities | Foreign governments
Financial Assets
Financial assets	0.2	0.2
Level 2 | Fixed maturity securities | Asset-backed
Financial Assets
Financial assets	0.1
Level 2 | Fixed maturity securities | Residential mortgage-backed
Financial Assets
Financial assets	4.1	4.5
Level 2 | Fixed maturity securities | U.S. corporate
Financial Assets
Financial assets	2.2	1.9
Level 2 | Fixed maturity securities | Foreign corporate
Financial Assets
Financial assets	0.4	0.3
Level 2 | Short-term investments
Financial Assets
Financial assets	0	0
Level 2 | Cash equivalents
Financial Assets
Financial assets	0	0
Level 2 | Assets held in separate accounts
Financial Assets
Financial assets	4.2	5.3
Level 3
Financial Assets
Financial assets	0	0
Financial Liabilities
Financial liabilities	0	0
Level 3 | Fixed maturity securities | U.S. government and government agencies and authorities
Financial Assets
Financial assets	0	0
Level 3 | Fixed maturity securities | States, municipalities and political subdivisions
Financial Assets
Financial assets	0	0
Level 3 | Fixed maturity securities | Foreign governments
Financial Assets
Financial assets	0	0
Level 3 | Fixed maturity securities | Asset-backed
Financial Assets
Financial assets	0
Level 3 | Fixed maturity securities | Residential mortgage-backed
Financial Assets
Financial assets	0	0
Level 3 | Fixed maturity securities | U.S. corporate
Financial Assets
Financial assets	0	0
Level 3 | Fixed maturity securities | Foreign corporate
Financial Assets
Financial assets	0	0
Level 3 | Short-term investments
Financial Assets
Financial assets	0	0
Level 3 | Cash equivalents
Financial Assets
Financial assets	0	0
Level 3 | Assets held in separate accounts
Financial Assets
Financial assets	0	0
Total
Financial Assets
Financial assets	21.8	21
Financial Liabilities
Financial liabilities	10.2	10.1
Total | Fixed maturity securities | U.S. government and government agencies and authorities
Financial Assets
Financial assets	1.8	1.8
Total | Fixed maturity securities | States, municipalities and political subdivisions
Financial Assets
Financial assets	0.5	0.5
Total | Fixed maturity securities | Foreign governments
Financial Assets
Financial assets	0.2	0.2
Total | Fixed maturity securities | Asset-backed
Financial Assets
Financial assets	0.1
Total | Fixed maturity securities | Residential mortgage-backed
Financial Assets
Financial assets	4.1	4.5
Total | Fixed maturity securities | U.S. corporate
Financial Assets
Financial assets	2.2	1.9
Total | Fixed maturity securities | Foreign corporate
Financial Assets
Financial assets	0.4	0.3
Total | Short-term investments
Financial Assets
Financial assets	1.6	1.6
Total | Cash equivalents
Financial Assets
Financial assets	0.7	0.1
Total | Assets held in separate accounts
Financial Assets
Financial assets	$ 10.2	$ 10.1

Fair Value Disclosures - Carryi

Fair Value Disclosures - Carrying Value, Fair Value, and Fair Value Hierarchy (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Carrying Value
Financial Liabilities
Policy reserves under investment products (Individual and group annuities, subject to discretionary withdrawal)	$ 4.8	$ 4.9
Fair Value
Financial Liabilities
Policy reserves under investment products (Individual and group annuities, subject to discretionary withdrawal)	5.3	5.1
Fair Value | Level 1
Financial Liabilities
Policy reserves under investment products (Individual and group annuities, subject to discretionary withdrawal)	0	0
Fair Value | Level 2
Financial Liabilities
Policy reserves under investment products (Individual and group annuities, subject to discretionary withdrawal)	0	0
Fair Value | Level 3
Financial Liabilities
Policy reserves under investment products (Individual and group annuities, subject to discretionary withdrawal)	$ 5.3	$ 5.1

Income Taxes - Income Tax Expen

Income Taxes - Income Tax Expense (Benefit) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Current and deferred federal tax expense (benefit)
Current expense	$ (0.2)	$ 0.3	$ 0.3
Deferred expense (benefit)	0.2	(0.5)	0
Total income tax expense	$ 0	$ (0.2)	$ 0.3

Income Taxes - Income Tax Recon

Income Taxes - Income Tax Reconciliation (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Federal income tax rate	21%	21%	21%
Reconciling items:
Tax exempt interest	(2.50%)	0.60%	(1.30%)
Dividend received deduction	(2.10%)	0.50%	(0.30%)
Other	(0.80%)	(0.30%)	0%
Effective income tax rate	15.60%	21.80%	19.40%
Unrecognized tax benefits (less than)	$ 0	$ 0	$ 0

Income Taxes - Deferred Tax Ass

Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Deferred tax assets
Deferred acquisition costs	$ 1,600,000	$ 1,600,000
Deferred gain on disposal of business	100,000	100,000
Investments, net	200,000	300,000
Net unrealized appreciation on securities	200,000	200,000
Other	200,000	300,000
Total deferred tax assets	2,300,000	2,500,000
Deferred tax liabilities
Net unrealized appreciation on securities	0	0
Total deferred tax liabilities	0	0
Net deferred income tax assets	2,300,000	$ 2,500,000
Cumulative valuation allowance against deferred tax assets	0
Net operating loss carryforward	$ 0

Stockholder's Equity (Details)

Stockholder's Equity (Details) - USD ($) $ / shares in Units, $ in Millions		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022		Dec. 31, 2021
Class of Stock [Line Items]
Authorized shares of common stock (in shares)		100,000	100,000
Par value of shares of common stock (in dollars per share)		$ 20	$ 20
Dividends paid	[1]	$ 0	$ 1.7		$ 1.2
Dividends			30	[2]	$ 1.2
Non-cash dividend			28.3
Additional Paid-in Capital
Class of Stock [Line Items]
Dividends	[2]		$ 28.9
[1]For the year ended 2022, the Company had a $28.3 million non-cash extraordinary dividend. See Note 7 for additional information.[2]Dividends are required to be deducted from retained earnings available as of the dividend date and when depleted, deducted from additional paid-in capital and treated as a return of capital.

Statutory Information - Reconci

Statutory Information - Reconciliation of Net Income and Stockholder's Equity on the Basis of Statutory Accounting (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Net Income
Net income (loss)	$ 0.2	$ (0.6)	$ 1.2
Stockholder's Equity
Total stockholder's equity	12.1	11.8	45.3	$ 46.5
New York Department of Commerce
Net Income
Based on SAP	(1)	(0.1)	1.1
Policy and claim reserves	1.1	0	0
Investment valuation difference	0	0	(0.1)
Current income taxes	(0.2)	0	0
Deferred taxes	(0.2)	0.5	0
Deferred gain on disposal of businesses and gains on disposal of businesses	0	0	0.1
Other differences	0.5	(1)	0.1
Net income (loss)	0.2	(0.6)	$ 1.2
Stockholder's Equity
Based on SAP	10.8	11.8
Policy and claim reserves	1.1	0
Investment valuation difference	(0.7)	(1)
Current income taxes	(0.2)	0
Deferred taxes	0.3	0.4
Deferred gain on disposal of businesses and gains on disposal of businesses	(0.4)	(0.6)
Other differences	1.2	1.2
Total stockholder's equity	$ 12.1	$ 11.8

Statutory Information - Narrati

Statutory Information - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Statutory Information
Non-cash dividend		$ 28,300,000
New York Department of Commerce
Statutory Information
Ordinary dividends declared and paid	$ 0	1,100,000
Extraordinary dividends declared and paid		600,000
Non-cash dividend		$ 28,300,000

Reinsurance - Schedule of Reins

Reinsurance - Schedule of Reinsurance Recoverable (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Reinsurance Disclosures [Abstract]
Ceded future policyholder benefits and expense	$ 335	$ 348.6
Ceded unearned premium	1.9	2
Ceded claims and benefits payable	100.6	101.8
Ceded paid losses	(0.2)	0.3
Total	$ 437.3	$ 452.7

Reinsurance - Schedule of Rei_2

Reinsurance - Schedule of Reinsurance Recoverables by A.M. Best Rating and Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($) reinsurer	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Ceded Credit Risk [Line Items]
Total	$ 437.6
Less: Allowance	(0.3)	$ (0.5)	$ (0.3)
Total Reinsurance recoverable	437.3
Net reinsurance recoverable	$ 437.3	$ 452.7
Number of reinsurers with the largest reinsurance recoverable balances | reinsurer	3
Ceded future policyholder benefits and expense
Ceded Credit Risk [Line Items]
Total	$ 335
Less: Allowance	0
Total Reinsurance recoverable	335
Ceded unearned premiums
Ceded Credit Risk [Line Items]
Total	1.9
Less: Allowance	0
Total Reinsurance recoverable	1.9
Ceded claims and benefits payable
Ceded Credit Risk [Line Items]
Total	100.6
Less: Allowance	0
Total Reinsurance recoverable	100.6
Ceded paid losses
Ceded Credit Risk [Line Items]
Total	0.1
Less: Allowance	(0.3)
Total Reinsurance recoverable	(0.2)
John Hancock, The Hartford and Sun Life
Ceded Credit Risk [Line Items]
Net reinsurance recoverable	436.9
A++ or A+
Ceded Credit Risk [Line Items]
Total	432.7
A++ or A+ | Ceded future policyholder benefits and expense
Ceded Credit Risk [Line Items]
Total	330.1
A++ or A+ | Ceded unearned premiums
Ceded Credit Risk [Line Items]
Total	1.9
A++ or A+ | Ceded claims and benefits payable
Ceded Credit Risk [Line Items]
Total	100.6
A++ or A+ | Ceded paid losses
Ceded Credit Risk [Line Items]
Total	0.1
B++ or B+
Ceded Credit Risk [Line Items]
Total	4.9
B++ or B+ | Ceded future policyholder benefits and expense
Ceded Credit Risk [Line Items]
Total	4.9
B++ or B+ | Ceded unearned premiums
Ceded Credit Risk [Line Items]
Total	0
B++ or B+ | Ceded claims and benefits payable
Ceded Credit Risk [Line Items]
Total	0
B++ or B+ | Ceded paid losses
Ceded Credit Risk [Line Items]
Total	$ 0

Reinsurance - Reinsurance Recov

Reinsurance - Reinsurance Recoverable by Reinsurer (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Ceded Credit Risk [Line Items]
Net reinsurance recoverable	$ 437.3	$ 452.7
John Hancock
Ceded Credit Risk [Line Items]
Net reinsurance recoverable	416.1	430
Assets held under trust under reinsurance agreement	879.4
Sun Life
Ceded Credit Risk [Line Items]
Net reinsurance recoverable	16.1	17.4
Talcott Resolution
Ceded Credit Risk [Line Items]
Net reinsurance recoverable	4.7	4.9
Other reinsurers
Ceded Credit Risk [Line Items]
Net reinsurance recoverable	$ 0.4	$ 0.4

Reinsurance - Effect of Reinsur

Reinsurance - Effect of Reinsurance Premiums (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Effect of reinsurance on premiums earned and benefits incurred
Direct earned premiums	$ 6.8	$ 7.4	$ 8.7
Premiums ceded	(6.6)	(7.1)	(8.2)
Net earned premiums	0.2	0.3	0.5
Direct policyholder benefits	32.7	31.7	32.4
Policyholder benefits ceded	(32.6)	(31.2)	(32.2)
Net policyholder benefits	0.1	0.5	0.2
Long Duration
Effect of reinsurance on premiums earned and benefits incurred
Direct earned premiums	6.5	7	8.1
Premiums ceded	(6.5)	(7)	(8.1)
Net earned premiums	0	0	0
Direct policyholder benefits	31.4	30.3	31.9
Policyholder benefits ceded	(31.4)	(30.3)	(31.9)
Net policyholder benefits	0	0	0
Short Duration
Effect of reinsurance on premiums earned and benefits incurred
Direct earned premiums	0.3	0.4	0.6
Premiums ceded	(0.1)	(0.1)	(0.1)
Net earned premiums	0.2	0.3	0.5
Direct policyholder benefits	1.3	1.4	0.5
Policyholder benefits ceded	(1.2)	(0.9)	(0.3)
Net policyholder benefits	$ 0.1	$ 0.5	$ 0.2

Reinsurance - Business Divestit

Reinsurance - Business Divestitures Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($) reinsurer
Ceded Credit Risk [Line Items]
Number of reinsurer insolvency for making company responsible for administering reinsurance business (at least) | reinsurer	1
John Hancock
Ceded Credit Risk [Line Items]
Assets held under trust under reinsurance agreement | $	$ 879.4

Reserves - Schedule of Policy B

Reserves - Schedule of Policy Benefits and Expense Reserve (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Jan. 01, 2021	Dec. 31, 2020
Present value of expected future policy benefits
Benefit payments	$ (420.9)	$ (434.9)
Future policy benefits and expenses	420.9	434.9
Long-term care
Present value of expected net premiums
Balance, beginning of period	34.2	37.1	$ 44.4
Beginning balance at original discount rate	33.4	29.2	33.7
Effect of changes in cash flow assumptions		1.5	9.4		$ (3.2)
Effect of actual variances from expected experience		3.5	(2.7)		(2.4)
Adjusted beginning of period balance		38.4	35.9		28.1
Experience variance	0	(0.3)	2.4
Interest accrual	2.8	4.6	6
Net premiums collected	(4.7)	(6.8)	(7.3)
Ending balance at original discount rate	36.5	33.4	29.2
Effect of changes in discount rate assumptions	(0.1)	0.8	7.9
Balance, end of period	36.4	34.2	37.1
Present value of expected future policy benefits
Balance, beginning of period	462.4	658.5	683.2
Beginning balance at original discount rate	444.4	430	421.7
Effect of change in cash flow assumptions		0	12.3		(1.2)
Effect of actual variances from expected experience		4.4	(3.3)		(2.7)
Adjusted beginning of period balance		448.8	439		$ 417.8
Experience variance	1	(1.2)	(0.4)
Interest accrual	19.5	24.7	29.3
Benefit payments	(16.3)	(18.1)	(16.7)
Ending balance at original discount rate	453	444.4	430
Effect of changes in discount rate assumptions	(2.4)	18	228.5
Balance, end of period	450.6	462.4	658.5
Future policy benefits and expenses	414.2	428.2	621.4
Related reinsurance recoverable	414.2	428.2	621.4	$ 638.8
Net future policy benefits and expenses, after reinsurance recoverable	$ 0	$ 0	$ 0	$ 0
Weighted-average liability duration of the future policy benefits and expenses (in years)	12 years	12 years 8 months 12 days	13 years

Reserves - Schedule of Reconcil

Reserves - Schedule of Reconciliation of Net Future Policy Benefits and Expenses To Balance Sheet Reserve (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Policyholder Account Balance [Line Items]
Future policy benefits and expenses	$ 420.9	$ 434.9
Long-term care
Policyholder Account Balance [Line Items]
Future policy benefits and expenses	414.2	428.2	$ 621.4
Other
Policyholder Account Balance [Line Items]
Future policy benefits and expenses	$ 6.7	$ 6.7

Reserves - Schedule of Future B

Reserves - Schedule of Future Benefit Payments and Expected Gross Premiums (Details) - Long-term care - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Policyholder Account Balance [Line Items]
Expected future benefits payments	$ 829.3	$ 850
Expected future gross premiums	$ 69.4	$ 76.2

Reserves- Schedule of Long-Term

Reserves- Schedule of Long-Term Care Revenue and Interest Recognized in the Statements of Operations (Details) - Long-term care - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Policyholder Account Balance [Line Items]
Gross premiums	$ 1.5	$ 1.7	$ 1.9
Interest expense (original discount rate)	$ 5.6	$ 4.7	$ 5.1

Reserves - Schedule of Interest

Reserves - Schedule of Interest Rate (Details) - Long-term care	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2020
Policyholder Account Balance [Line Items]
Interest expense (original discount rate)	5.95%	5.95%	5.95%
Current discount rate	6.01%	5.52%	1.69%

Reserves - Narrative (Details)

Reserves - Narrative (Details) - Long-term care	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2020
Policyholder Account Balance [Line Items]
Interest expense (original discount rate)	5.95%	5.95%	5.95%
Current discount rate	6.01%	5.52%	1.69%

Reserves - Schedule of Reserves

Reserves - Schedule of Reserves Roll Forward (Details) - Long-term care - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Jan. 01, 2021	Dec. 31, 2020
Policyholder Account Balance [Line Items]
Future Policy Benefits and Expenses, pre-adoption December 31, 2020	$ 450.6	$ 462.4	$ 658.5	$ 638.8	$ 683.2
Effect of change in cash flow assumptions		0	12.3		(1.2)
Adjusted balance, beginning of January 1, 2021	450.6	462.4	658.5	638.8	683.2
Related reinsurance recoverable	(414.2)	(428.2)	(621.4)	(638.8)
Net future policy benefits and expenses, after reinsurance recoverable	$ 0	$ 0	$ 0	$ 0
Previously Reported
Policyholder Account Balance [Line Items]
Future Policy Benefits and Expenses, pre-adoption December 31, 2020					386.4
Adjusted balance, beginning of January 1, 2021					386.4
Effect of the remeasurement of the liability at current discount rate
Policyholder Account Balance [Line Items]
Effect of change in cash flow assumptions					250.8
Adjustment for loss contracts with NPR in excess of 100% under the modified retrospective approach
Policyholder Account Balance [Line Items]
Effect of change in cash flow assumptions					$ 1.6

Reserves - Schedule Of Adjustme

Reserves - Schedule Of Adjustments on Stockholder's Equity (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2020
Policyholder Account Balance [Line Items]
Accumulated other comprehensive income	$ (0.6)	$ (0.7)
Retained earnings (deficit)	$ 0	$ (0.2)
Long-term care
Policyholder Account Balance [Line Items]
Accumulated other comprehensive income			$ (250.8)
Retained earnings (deficit)			$ (1.6)

Reserves - Roll Forward of Shor

Reserves - Roll Forward of Short Duration Claims and Benefits Payable Balances (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]
Claims and benefits payable, at beginning of year	$ 17.1	$ 19.1	$ 22.5
Less: Reinsurance ceded and other	(17)	(19)	(22.4)
Net claims and benefits payable, at beginning of year	0.1	0.1	0.1
Incurred losses and loss adjustment expenses related to:
Current Year	0.9	0.1	0.3
Prior years	(0.8)	0	0
Total incurred losses and loss adjustment expenses	0.1	0.1	0.3
Paid losses and loss adjustment expenses related to:
Current year	0.1	0.1	0.2
Prior years	0	0	0.1
Total paid losses and loss adjustment expenses	0.1	0.1	0.3
Net claims and benefits payable, at end of year	0.1	0.1	0.1
Plus: Reinsurance ceded and other	15.6	17	19
Claims and benefits payable, at end of year	$ 15.7	$ 17.1	$ 19.1

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income - Reclassification Adjustments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning Balance	$ 11.8	$ 45.3	$ 46.5
Change in accumulated other comprehensive income (loss) before reclassifications	0.1	(3.8)	(1.1)
Amounts reclassified from accumulated other comprehensive income (loss)	0	0.9	(0.1)
Net current-period other comprehensive income (loss)	0.1	(2.9)	(1.2)
Ending Balance	12.1	11.8	45.3
Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning Balance	(0.7)	2.2	3.4
Ending Balance	$ (0.6)	$ (0.7)	$ 2.2

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Income - Reclassifications Out of AOCI (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Amount reclassified from accumulated other comprehensive income
Net realized (losses) gains on investments	$ 0	$ (1.1)	$ 0.2
(Benefit) provision for income taxes	0	(0.2)	0.3
Net income (loss)	0.2	(0.6)	1.2
AOCI | Reclassified from AOCI
Amount reclassified from accumulated other comprehensive income
Net realized (losses) gains on investments	0	1.1	(0.1)
(Benefit) provision for income taxes	0	(0.2)	0
Net income (loss)	$ 0	$ 0.9	$ (0.1)

Related Party Transactions (Det

Related Party Transactions (Details) - Parent and its affiliates - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Related Party Transactions
Amount paid for services and obligations	$ 0.4	$ 0.5	$ 0.3
Tax payment	$ 0.1	$ 0.3	$ 0.2

Schedule I-Summary of Investm_2

Schedule I-Summary of Investments Other-Than-Investments in Related Parties (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Summary of Investments Other-Than-Investments in Related Parties
Cost or Amortized Cost	$ 11.6
Fair Value	10.9
Amount at which shown in balance sheet	10.9	$ 10.8
Fixed maturity securities
Summary of Investments Other-Than-Investments in Related Parties
Cost or Amortized Cost	10
Fair Value	9.3
Amount at which shown in balance sheet	9.3
U.S. government and government agencies and authorities
Summary of Investments Other-Than-Investments in Related Parties
Cost or Amortized Cost	1.9
Fair Value	1.8
Amount at which shown in balance sheet	1.8
States, municipalities and political subdivisions
Summary of Investments Other-Than-Investments in Related Parties
Cost or Amortized Cost	0.5
Fair Value	0.5
Amount at which shown in balance sheet	0.5
Foreign governments
Summary of Investments Other-Than-Investments in Related Parties
Cost or Amortized Cost	0.2
Fair Value	0.2
Amount at which shown in balance sheet	0.2
Asset-backed
Summary of Investments Other-Than-Investments in Related Parties
Cost or Amortized Cost	0.1
Fair Value	0.1
Amount at which shown in balance sheet	0.1
Residential mortgage-backed
Summary of Investments Other-Than-Investments in Related Parties
Cost or Amortized Cost	4.8
Fair Value	4.1
Amount at which shown in balance sheet	4.1
U.S. corporate
Summary of Investments Other-Than-Investments in Related Parties
Cost or Amortized Cost	2.1
Fair Value	2.2
Amount at which shown in balance sheet	2.2
Foreign corporate
Summary of Investments Other-Than-Investments in Related Parties
Cost or Amortized Cost	0.4
Fair Value	0.4
Amount at which shown in balance sheet	0.4
Short-term investments
Summary of Investments Other-Than-Investments in Related Parties
Cost or Amortized Cost	1.6
Fair Value	1.6
Amount at which shown in balance sheet	$ 1.6

Schedule III-Supplementary In_2

Schedule III-Supplementary Insurance Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract]
Future policy benefits and expenses	$ 420.9	$ 434.9	$ 628.3
Unearned premiums	1.9	2	2.2
Claims and benefits payable	15.7	17.1	19.2
Premium revenues	0.2	0.3	0.5
Net investment income	0.4	1.3	1.3
Benefits claims, losses and settlement expenses	0.1	0.5	0.2
Other operating expenses	$ 0.5	$ 1	$ 0.5

Schedule IV-Reinsurance (Detail

Schedule IV-Reinsurance (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Life Insurance in Force
Direct amount	$ 14.9	$ 16.7	$ 29.5
Ceded to other companies	12.4	13.7	15.8
Assumed from other companies	0	0	0
Net amount	$ 2.5	$ 3	$ 13.7
Percentage of amount assumed to net	0%	0%	0%
Premiums:
Direct amount	$ 6.8	$ 7.4	$ 8.7
Ceded to other companies	6.6	7.1	8.2
Assumed from other companies	0	0	0
Net earned premiums	$ 0.2	$ 0.3	$ 0.5
Percentage of amount assumed to net	0%	0%	0%
Benefits:
Direct amount	$ 32.7	$ 31.7	$ 32.4
Ceded to other companies	32.6	31.2	32.2
Assumed from other companies	0	0	0
Net policyholder benefits	$ 0.1	$ 0.5	$ 0.2
Percentage of amount assumed to net	0%	0%	0%
Life insurance
Premiums:
Direct amount	$ 0.1	$ 0.2	$ 0.8
Ceded to other companies	0.1	0.2	0.7
Assumed from other companies	0	0	0
Net earned premiums	$ 0	$ 0	$ 0.1
Percentage of amount assumed to net	0%	0%	0%
Benefits:
Direct amount	$ 0.7	$ 0.5	$ 1.4
Ceded to other companies	0.7	0.5	1.3
Assumed from other companies	0	0	0
Net policyholder benefits	$ 0	$ 0	$ 0.1
Percentage of amount assumed to net	0%	0%	0%
Accident and health insurance
Premiums:
Direct amount	$ 6.7	$ 7.2	$ 7.9
Ceded to other companies	6.5	6.9	7.5
Assumed from other companies	0	0	0
Net earned premiums	$ 0.2	$ 0.3	$ 0.4
Percentage of amount assumed to net	0%	0%	0%
Benefits:
Direct amount	$ 32	$ 31.2	$ 31
Ceded to other companies	31.9	30.7	30.9
Assumed from other companies	0	0	0
Net policyholder benefits	$ 0.1	$ 0.5	$ 0.1
Percentage of amount assumed to net	0%	0%	0%